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Abstract 1
1 Abstract 
Influenza A virus, the causative agent of the flu, is a widely spread pathogen in humans and some 
animal species. Membrane rafts have been shown to be the cellular budding sites of this enveloped 
virus. Rafts are dynamic sphingolipid and cholesterol-rich membrane microdomains that serve as 
platforms for multiple processes like membrane sorting, signal transduction, cell adhesion and 
pathogen entry by the recruitment and concentration of effectors. Annexin A2, a Ca2+-regulated 
membrane- and actin-binding protein of the annexin family, is one of the few known structural 
components on the cytosolic site of such microdomains. It has been implicated in regulating the 
aggregation and stabilisation of rafts. Furthermore, it is involved in endo- and exocytotic processes 
and membrane-cytoskeleton organisation. Since all of these events play a role in influenza A virus 
replication the involvement of annexin A2 in this process was investigated. 
siRNA mediated down-regulation of annexin A2 in A549 or HeLa cells revealed that influenza A virus 
replication efficiency was not dependent on cytosolic annexin A2 protein levels. Further, in MDCK the 
aggregation of annexin A2 by a dominant-negative construct does not influence influenza A replication 
and in an endothelial cell line from the annexin A2 knockout mouse this virus efficiently replicates.  
Next, the surface localisation of the raft-associated influenza protein hemagglutinin was analysed and 
found to be not affected by annexin A2 depletion in non-polarised A549. Furthermore, real-time PCR 
analysis did not reveal a difference in the mRNA level of annexin A2 between influenza infected in 
comparison to uninfected A549, HeLa and HepG2 cells.  
However, although no colocalisation of annexin A2 with virus particles in influenza A infected A549 
could be detected, annexin A2 was found to be associated with purified influenza A virus particles. 
Whether this incorporation is of critical importance for influenza A infectivity remains to be determined. 
Collectively, the experimental data obtained in this thesis implicate that annexin A2 is not actively 
involved in influenza A replication.  
 
Influenza A virus induces apoptosis in infected cells. The role of annexin A2 in this process was 
analysed in the second part of this thesis. Cells with reduced annexin A2 were found to be more 
susceptible to influenza A-induced apoptosis, as revealed by apoptotic morphological changes and 
enhanced PARP cleavage. An increased sensitivity towards apoptosis upon annexin A2 depletion was 
also observed when apoptosis was induced with other agents, like staurosporine and TNF, in A549 
and HeLa cells. Not only PARP is cleaved to a greater extent but also the activation of the initiator 
caspases 8 and 9 is enhanced in annexin A2 depleted HeLa. However, the mechanism of action of 
annexin A2 in the apoptotic pathways could not be resolved. 
 
The lateral organisation of cellular membranes in rafts does not only play a role in influenza A infection 
but also in various other host-pathogen interactions. Since annexin A2 is involved in the aggregation 
and stabilisation of membrane rafts the binding of annexin A2 to these membrane microdomains was 
studied in more detail in the third part of this thesis. The aim was to elucidate which functions of this 
protein are involved in raft association and thereby possibly are of importance for the organisation and 
function of membrane rafts in living cells. 
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Annexin A2 not only exists as a monomer but also in a heterotetrameric form, where two annexin A2 
molecules are bridged via a dimer of the S100 protein p11. Thus, the impact of this p11-binding for raft 
association was investigated. Furthermore, the effects of phosphorylation on Tyr23, PI(4,5)P2-binding 
and Ca2+-binding of annexin A2 were analysed by employing the respective annexin A2 mutants. 
Raft association of these annexin A2 derivatives was revealed by binding to detergent resistant 
membranes, by segregation with raft lipids in plasma membrane spheres and by colocalisation with 
lipid ordered domains identified by Laurdan 2-photon microscopy. While the latter techniques did not 
reveal any conclusive results yet, the analysis of plasma membrane spheres indicates a raft 
association of all annexin A2 derivatives at elevated Ca2+ concentrations. The detergent extraction 
showed that only p11-binding deficient monomeric mutants of annexin A2 show reduced binding to 
rafts. All other mutations had no effect. From these data it could be concluded that binding to p11 is of 
regulating importance for the association of annexin A2 with membrane rafts in vivo. 
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2 Introduction 
2.1 The influenza A virus 
2.1.1 Pathogen-host interactions 
Infectious diseases provoke 25 % of deaths worldwide and therewith are the second most common 
cause of death (World Health Organization, 1999). These diseases result from the presence of 
pathogenic microbial agents in the host organism. Infection with some of these agents might also 
result in other secondary causes of death like cardiovascular diseases or cancer. 
The interactions between a pathogen and its host are complex and dynamic. All pathogenic organisms 
(bacteria, viruses, fungi and parasites) initially contact surfaces of cellular barriers. This is followed by 
the induction of specific signal transduction pathways resulting in host responses. Fundamental 
understanding of the molecular mechanisms underlying these interactions can help eradicate life 
threatening diseases and improve life quality and expectancy. 
2.1.2 General properties of the influenza A virus 
Influenza A viruses (IAV) are important worldwide pathogens for humans and different animal species. 
They are the infectious agent of the flu and still cause thousands of deaths and an enormous 
economic loss every year. 
IAV belong to the family orthomyxoviridae which are characterised by a segmented linear negative-
sense single-stranded RNA genome. These viruses can further be classified based on the antigenic 
properties of the surface glycoproteins hemagglutinin (HA) and neuraminidase (NA). Sixteen HA 
subtypes and nine NA subtypes of IAV have been identified so far. 
This virus possesses eight genome segments encoding for eleven proteins. These proteins include the 
three components of the viral RNA-dependent RNA polymerase complex (PB2, PB1 and PA), two 
surface glycoproteins (HA and NA), two matrix proteins (M1 and M2), one nucleoprotein (NP) and a 
nuclear export protein (NEP). The PB1 genome segment of many but not all IAV strains also contains 
a +1 reading frame encoding the PB1-F2 protein (Chen et al., 2001). This protein as well as the non-
structural protein 1 (NS1) are not incorporated into the virion. Therefore, the virion consists of nine 
structural proteins, eight genome segments and an envelope which originates from the host cell. A 
schematic presentation of IAV structure is depicted in Figure 2-1. For a detailed review see Cheung 
and Poon, 2007. 
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Figure 2-1: Structure of the influenza A virion 
The eight viral RNA segments are surrounded by a membrane which originates from the host cell. The 
localisation of the different viral structural proteins within the virus particle is indicated. NP (green) binds to the 
vRNA segments to form ribonucleoprotein (RNP) complexes. PB1, PB2 and PA (red) are also associated with the 
RNPs. The viral glycoproteins HA (blue) and NA (yellow) are exposed on the virus surface. M1 (dark red) forms 
the inner layer of the virion whereas M2 (orange), which is a pH dependent ion channel, is a transmembrane 
protein. NEP (grey) is also incorporated into the virus particle. From Ludwig et al., 2003. 
2.1.3 The influenza A replication cycle 
Viruses need a cell of their host to propagate. A schematic presentation of the IAV replication cycle is 
depicted in Figure 2-2. As a first step HA of influenza A binds to sialic-acid containing receptors on the 
apical side of polarised epithelial cells (Dimmock, 1982). Subsequently the virus enters the cell via 
multiple endocytotic pathways (Lakadamyali et al., 2004) and reaches endosomal compartments. 
Acidification of the endosome environment induces conformational changes in the HA, mediating 
fusion between the viral envelope and the endosomal membrane. For this event as well as for the 
receptor binding a cleaved form of HA (into HA1 and HA2) is essential. This proteolytic activation is 
mediated by proteases of the host and is a prime determinant of influenza pathogenicity. HA of low 
pathogenic avian influenza strains have a single arginine at the cleavage site and are activated by 
trypsin-like proteases restricted to enteric or respiratory epithelia. In contrast the HA of highly 
pathogenic avian influenza strains posses a series of basic amino acids at the cleavage site, which are 
cleaved by ubiquitous proteases such as furin (Horimoto and Kawaoka, 2005). 
After the fusion event the viral RNA is released into the cytoplasm and transported into the nucleus 
where amplification of the genome and transcription take place. Viral mRNA is translated in the 
cytoplasm. At late time points of the viral infection cycle the viral genome is transported out of the 
nucleus in the form of RNP complexes. The influenza surface glycoproteins HA and NA are post-
translationally modified in the Golgi network and transported to the cell surface for integration into the 
cellular membrane. In this membrane these proteins preferentially localise to membrane microdomains 
called rafts. The local concentration of the cytoplasmic tails of HA and NA leads to the recruitment of 
the influenza matrix protein M1 and RNPs (Suomalainen, 2002). Hence, the virus assembles and buds 
from the cell surface at sites of membrane rafts. The replication cycle is completed within 6 - 16 h, 
depending on the particular virus strain and the cell type. 
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Figure 2-2: The lifecycle of influenza A 
IAV binds to receptors on the cell surface and is endocytosed. The viral and endosomal membrane fuse thereby 
releasing the viral genome into the cytoplasm. The genome is transported into the nucleus where it is transcribed 
and replicated. Viral proteins are synthesised in the cytoplasm. The vRNAs as well as the viral proteins assemble 
at the plasma membrane from where new virions finally bud. For a detailed explanation see text. From Ludwig et 
al., 2003. 
 
Taking into account that the genome of influenza A is relatively small - coding only for up to eleven 
viral proteins - it is not surprising that a whole range of cellular proteins and cellular processes are 
employed and manipulated by the virus to efficiently replicate. This includes numerous interactions of 
viral proteins with cellular proteins. The virus thereby manipulates e.g. the cellular protein expression 
machinery, intracellular transport processes or the host cell defence (Ludwig et al., 1999). The role of 
cellular proteins involved in IAV replication is only beginning to emerge and an understanding of these 
processes could help in developing strategies for fighting the infectious agent of the flu. 
2.1.4 Influenza A and apoptosis 
Influenza virus causes apoptosis of the infected cells at late stages of infection (Hinshaw et al., 1994). 
Apoptosis is a morphologically and biochemically defined form of cell death (Kerr et al., 1972) and it 
results in changes like chromatin condensation, DNA fragmentation, cell shrinkage, externalisation of 
phosphatidylserine, membrane blebbing or budding and formation of apoptotic bodies (Earnshaw, 
1995; Martin et al., 1995). The most important cellular proteins for the onset of apoptosis belong to a 
family of cysteine proteases called caspases that exist as inactive zymogens in normal cells (Salvesen 
and Dixit, 1997). Apoptosis relies on a complex interplay of a whole range of proteins and can be 
induced in response to various signals from inside and outside of cells. 
Internal stimuli frequently have their origin within the nucleus. E.g. DNA damage induced by 
irradiation, drugs or other sort of stress in most cases results in the activation of the p53 transcription 
factor which promotes expression of proapoptotic Bcl-2 members (Chipuk et al., 2004) and 
suppresses antiapoptotic Bcl-2 and Bcl-XL (Wu et al., 2001). Proapoptotic members of the Bcl-2 family 
regulate the exit of cytochrome c and other proapoptotic molecules from the mitochondria into the 
cytosol (Green and Reed, 1998). In the cytosol cytochrome c forms a multimeric complex with the 
adaptor protein Apaf-1, procaspase-9 and dATP, the apoptosome (Adams and Cory, 2002). This 
complex formation results in the activation of caspase-9 which is an initiator caspase and thus is able 
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to trigger the caspase cascade including the effector caspases-3, -6 and -7. Cleavage of caspase 
substrates eventually leads to the characteristic morphological and biochemical features of apoptosis. 
Extracellular apoptosis-inducing signals involve a whole range of soluble and membrane bound 
molecules, especially those of the family of tumour necrosis factors (TNF) (Locksley et al., 2001). 
When a death ligand, such as the Fas ligand (FasL), interacts with its cell surface receptor (i.e., Fas, a 
member of the TNF receptor family) a death-inducing signal complex (DISC) is formed (Nagata, 1999). 
The initiator caspase-8 is activated which results in the activation of a caspase cascade and 
subsequently in the induction of apoptosis. 
Activated caspase-8 also cleaves Bid, which translocates from the cytosol into the mitochondrial 
membrane, where it stimulates cytochrome c release and subsequent caspase-9 activation. Thus, the 
extrinsic and intrinsic apoptotic pathways converge through Bid (Li et al., 1998). 
 
There are also negative regulators of apoptosis. Members of the IAP (inhibitor of apoptosis) family 
directly inhibit caspases. IAP expression can be up-regulated in response to survival signals 
(Budihardjo et al., 1999). Of central importance are also the antiapoptotic Bcl-2 family members such 
as Bcl-2 and Bcl-XL which counteract the action of proapoptotic Bcl-2 proteins and thus can inhibit 
mitochondrial proapoptotic events. 
 
An overview of the major apoptotic pathways is given in Figure 2-3. Aside from these pathways also 
caspase-independent apoptotic pathways have been described. E.g. apoptosis inducing factor (AIF) is 
a caspase-independent mitochondrial death effector (Daugas et al., 2000). Furthermore, other 
organelles besides mitochondria and the nucleus, such as the ER and lysosomes, also have been 
implicated in apoptotic signalling pathways (Ivanova et al., 2008; Mund et al., 2003), which stresses 
the fact that the regulation of apoptosis is a fine-tuned mechanism involving presumably hundreds of 
proteins. 
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Figure 2-3: Schematic representation of the major apoptotic signalling pathways 
Apoptosis-inducing mechanisms can be classified into two major groups: an extrinsic receptor mediated pathway 
and an intrinsic mitochondria mediated pathway. These pathways are explained in detail in the text. From Gewies, 
2003. 
 
Apoptosis is thought to play an important role in the pathogenesis of many infectious diseases 
including those caused by viruses (Collins, 1995). The mechanisms involved in the process of 
influenza-induced apoptosis are only partly understood. Cellular as well as viral factors are of 
importance for this process. 
One influenza protein that has been shown to be involved in apoptosis induction is the NA, which 
activates latent transforming growth factor . This protein is a multifunctional growth-regulatory protein 
that induces apoptosis in many cell types (Schultz-Cherry and Hinshaw, 1996). There is evidence that 
the non-structural viral protein NS1 is able to initiate apoptosis when it is expressed in the cells alone 
(Schultz-Cherry et al., 2001) but on the other hand an interferon-dependent antiapoptotic potential of 
this protein has also been described (Zhirnov et al., 2002). Furthermore, the PB1-F2 protein has been 
shown to induce cell death by influencing the mitochondrial permeability during apoptosis (Chen et al., 
2001; Zhirnov et al., 2002). 
Induction of apoptosis at first seems to be disadvantageous for virus replication because it is a host 
mechanism to limit virus production. But it has been shown that the activation of caspase-3 is 
important in replication and propagation of IAV (Wurzer et al., 2003) and expression of antiapoptotic 
Bcl-2 reduces the level of infectious virus production (Olsen et al., 1996). Furthermore, the induction of 
apoptosis by influenza virus has been shown to limit the release of proinflammatory cytokines (Brydon 
et al., 2003). 
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2.2 Annexin A2 
2.2.1 The annexin protein family 
Annexins are a family of Ca2+-regulated phospholipid-binding proteins. The name annexin originates 
form the Greek word annex, meaning “to bring/hold together”. This reflects the principle property of 
nearly all annexins, i.e. the binding to and possibly holding together of certain biological structures, in 
particular membranes (Gerke and Moss, 2002). 
Annexins were identified in all eukaryotic phyla (Morgan et al., 2004). In vertebrates there are twelve 
annexin subfamilies (annexin A1 - annexin A11 and annexin A13). Annexins outside vertebrates are 
classified into families B (in invertebrates), C (in fungi and some groups of unicellular eukaryotes), D 
(in plants) and E (in protists). This protein family is absent from prokaryotes (Moss and Morgan, 2004). 
 
conserved
core domain
variable
N-terminus
 
 
Figure 2-4: Schematic presentation of an annexin associated with a membrane 
This drawing shows an annexin that is peripherally attached to a membrane surface through bound Ca2+ ions 
(red). Annexins possess a conserved core domain which consists of four annexin repeats. The variable 
N-terminal domain harbours sites for posttranslational modifications and protein-protein interactions. 
 
All annexin family members share a homologous molecular structure which is depicted in Figure 2-4. 
They consist of two domains: a highly conserved protein core and a regulatory N-terminal domain. The 
core domain is composed of four homologous segments (exception: annexin A6 has 8 segments), the 
so-called annexin repeats. Each repeat spans 70 - 80 amino acids and is made up of five -helices 
which are connected by turns or short loops. The annexin core domain forms a slightly curved disc. 
The convex side of this disc faces the membrane when an annexin is associated peripherally with 
phospholipids. This side also contains characteristic types of Ca2+-binding sites, the so-called type II 
and type III sites differing in their architecture and Ca2+ affinity (Jost et al., 1994). Although the general 
folding of the annexin core domain is highly similar for the members analysed so far, annexins show 
differences in the number and location of the individual Ca2+-binding sites. This might explain the 
differences in Ca2+ sensitivity and phospholipid specificity observed within this protein family. 
The N-terminal annexin domain is diverse in sequence and length. It mediates the interaction with 
specific target proteins and regulates the annexin-membrane association (for a review, see Gerke and 
Moss, 2002). The N-terminus is located on the concave side of the annexin core opposite the 
membrane-binding surface and forms a separate entity. It harbours sites for posttranslational 
modifications. 
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Annexins are able to interact with a whole range of proteins. Ligand-binding sites are mainly localised 
in the N-terminus which in some cases also harbours a binding site for S100 proteins. S100 proteins 
are members of the EF-hand superfamily of Ca2+-binding proteins. They have a size of about 
10 - 14 kDa and transmit Ca2+-dependent cell-regulatory signals. For a review on S100 proteins see 
Donato, 1999 or Schafer and Heizmann, 1996. S100 proteins appear intracellularly as dimers. Upon 
Ca2+ binding, S100 dimers are able to crossbridge two homologous or heterologous target proteins 
(Donato, 2001). Therefore, some S100 proteins are also able to form symmetric heterotetramers with 
annexins. 
In addition to the interaction partners of the S100 family some annexins also were shown to bind 
cytoskeletal proteins like F-actin and spectrin (Hayes et al., 2004). Furthermore, binding to other 
ligands, ranging from proteins to RNA, has been described (for a review see Gerke and Moss, 2002; 
Raynal and Pollard, 1994). 
 
Annexins are generally cytosolic proteins, but several members of this family are also stably or 
transiently associated with the cytoskeleton or cellular membranes. The expression level and tissue 
distribution of annexins varies extremely, probably reflecting the importance of gene regulation in the 
context of cell-type specific functions. Some annexins, such as annexin A1, A2, A4, A5, A6, A7 and 
A11 show a rather ubiquitous expression (Gerke and Moss, 1997), whereas e.g. annexin A3 is mainly 
expressed in neutrophils (Le Cabec and Maridonneau-Parini, 1994). 
Some annexins have been found in the nucleus. E.g. In this compartment annexin A11 seems to be 
involved in the progression of cytokinesis (Tomas et al., 2004). Furthermore, annexin A2 has been 
shown to bind RNA {{261 Vedeler,A. 2000}}. 
Even though this protein family lacks an export signal several members were identified extracellularly. 
These include annexin A1, an important endogenous modulator of inflammation (Perretti and Gavins, 
2003), annexin A5 that has been suggested to play an antithrombotic role (Raynal and Pollard, 1994) 
and annexin A2 which is found on the surface of vascular endothelial cells where it functions in the 
regulation of blood clotting (Brownstein et al., 2001). 
 
Some of the posttranslational modifications of annexins implicate a role of this protein family in signal 
transduction. Annexin A1 is phosphorylated by the epidermal growth factor (EGF) receptor tyrosine 
kinase (Fava and Cohen, 1984; Pepinsky and Sinclair, 1986) and annexin A2 was identified as a 
substrate for protein tyrosine kinase of Rous sarcoma virus pp60src (Erikson and Erikson, 1980; 
Radke et al., 1980). Furthermore, almost all annexins are both in vitro and in vivo substrates for 
protein kinase C (PKC) (Dubois et al., 1996). Since protein kinases play an important role in cancer 
development and progression an involvement of annexins in cancer related processes has been 
suggested (Bastian, 1997; Hayes et al., 2004). 
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The physiological functions of annexins are only beginning to emerge since they are very diverse 
(Rescher and Gerke, 2004). A central feature that can be related to a range of cellular functions is the 
regulated binding to negatively charged phospholipids. The ability to bind to lipids argues for a role of 
annexins in membrane transport processes. Annexins have been implicated to be involved in diverse 
endocytotic processes, as reviewed in Futter and White, 2007. And it has also been shown that they 
are of importance for exocytotic processes (Creutz, 1992). 
2.2.2 Specific properties and functions of annexin A2 
2.2.2.1 The annexin A2/p11 complex 
Annexin A2 is one of the best characterised members of the annexin protein family. It is able to bind 
the S100 protein S100A10, also called p11. This binding leads to the formation of a symmetric 
heterotetramer consisting of two annexin A2 molecules that are bridged by a p11 homodimer. The 
interaction site for p11 is localised in the amino acids 1 - 14 in the N-terminus of annexin A2 (Johnsson 
et al., 1988). 
In contrast to other S100 proteins p11 is unable to bind Ca2+. It harbours mutations in the EF-hand 
Ca2+-binding motif (Gerke and Weber, 1985) and therefore is locked in an active state with respect to 
annexin A2 binding (Johnsson et al., 1990). So far, endogenous p11 has not been purified from 
tissues or cells in the absence of annexin A2, indicating that the unbound protein is metabolically 
instable (He et al., 2008; Puisieux et al., 1996). Annexin A2 not only interacts with p11 but also with 
other members of the S100 family, like S100A11 (Rintala-Dempsey et al., 2006), S100A4 (Semov et 
al., 2005) and S100A6 (Filipek et al., 1991). 
Intracellular annexin A2 predominantly exists in complex with p11. This complex formation alters some 
of the biophysical properties of annexin A2. The tetramer can aggregate vesicles at micromolar Ca2+ 
levels, whereas the subunits of this complex are inactive in promoting granule aggregation at low Ca2+ 
concentrations (Drust and Creutz, 1988). Furthermore, monomeric annexin A2 needs higher Ca2+ 
levels for binding to phospholipids and membranes (Evans and Nelsestuen, 1994). On the other hand 
the p11 binding is dispensable for the association of annexin A2 with endosomal membranes. This 
process is independent of Ca2+ ions but requires an N-terminal binding site (Jost et al., 1997). 
2.2.2.2 Annexin A2 localisation 
Like other members of the annexin family annexin A2 is cytosolic but it is also bound to cytoskeletal 
components and membranes. Annexin A2 binds membranes in a Ca2+-dependent manner. It harbours 
different Ca2+-binding sites at the convex surface of the core domain. Three so-called type II sites are 
found in annexin repeats 2, 3 and 4, respectively. Two so-called type III sites are located in the first 
repeat. The type II binding sites have a much higher affinity for the divalent cation than the type III 
sites and are thought to be essential for the intracellular association of annexin A2 with the 
submembraneous cytoskeleton (Jost et al., 1994). But also a Ca2+-independent membrane association 
of annexin A2 has been described which depends on cholesterol (Harder et al., 1997). 
In addition to the cytoplasmic and membrane-bound localisation annexin A2 has been detected in the 
nucleus. Annexin A2 harbours a nuclear export sequence in the N-terminus and is actively exported 
after entering the nucleus. This nuclear exclusion might be modulated by phosphorylation (Eberhard et 
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al., 2001). Furthermore, annexin A2 is associated to cytoskeleton-associated polysomes and is 
capable of binding specific mRNAs (Vedeler et al., 2000). 
Although it lacks a signal peptide and its mechanism of secretion is unknown, extracellular annexin A2 
has been found in several tissues as both soluble and membrane-bound protein (Siever and Erickson, 
1997). Extracellular annexin A2 is involved in the activation of plasminogen by tissue plasminogen 
activator and therefore plays a role in fibrinolysis (Hajjar et al., 1994). The extracellular form of this 
protein might also be important for other biological processes, such as cell adhesion (Tressler et al., 
1993), ligand-mediated cell signalling (Chung et al., 1996) and virus infection (Wright et al., 1995). 
2.2.2.3 Binding of annexin A2 to membrane microdomains and the cytoskeleton 
The cytoskeletal scaffolding protein spectrin has been defined as an interaction partner of annexin A2 
(Gerke and Weber, 1984). Furthermore, annexin A2 binds F-actin and displays a Ca2+-dependent 
actin filament bundling activity which is more pronounced for the heterotetrameric annexin A2/p11 
complex (Waisman, 1995). The F-actin-binding site is located in the annexin core (Filipenko and 
Waisman, 2001). Annexin A2 is not a general bundling factor for F-actin because it needs cellular 
membranes for its recruitment to sites of actin rearrangement (Hayes et al., 2004). This is supported 
by the observation that annexin A2 is involved in the formation of actin comet tails of moving 
pinosomes, whereas it is not involved in the formation of actin tails propelling the pathogen Listeria 
monocytogenes (Merrifield et al., 2001). 
 
Annexin A2 is involved in a whole range of membrane transport process like endocytosis and 
exocytosis (Gerke et al., 2005; Futter and White, 2007), including the apical transport of vesicles in 
polarised cells, specifically vesicles that carry membrane raft-associated proteins (Jacob et al., 2004). 
 
Annexin A2 is one of the few known structural proteins on the cytosolic site of membrane 
microdomains enriched in sphingolipids and cholesterol, termed lipid rafts. These rafts provide a 
means for cellular membranes to locally concentrate effectors to form platforms that function e.g. in 
signal transduction, membrane trafficking, cell polarisation and pathogen entry (Simons and Ikonen, 
1997; Simons and Toomre, 2000). A key feature that is thought to contribute to raft assembly is the 
fact that cholesterol packs tightly with saturated acyl chains of lipids causing them to adopt an 
extended conformation in model membranes (Ipsen et al., 1987). This results in the induction of 
different phases which have a different degree of packing order. Therefore, cholesterol containing 
microdomains can be referred to as liquid ordered (lo) in contrast to liquid disordered (ld) membrane 
phases. Originally defined biochemically as detergent resistant membrane (DRM) fractions, rafts are 
proposed to be highly dynamic, submicroscopic assemblies that float freely within the liquid disordered 
bilayer in cell membranes and can coalesce upon clustering of their components. 
Several mammalian viruses like influenza, human immunodeficiency virus (HIV), measles and ebola 
bud from lipid rafts (Suomalainen, 2002). But these microdomains also serve as preferential sites for 
other host-pathogen interactions. E.g. the pore forming toxin aerolysin from Aeromonas hydrophila 
directly binds a GPI-anchored protein localised in rafts (Abrami et al., 1998). CD48 is also a GPI-linked 
raft resident protein that serves as a receptor for the FimH protein of some E. coli strains. This binding 
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triggers the internalisation of the pathogen (Baorto et al., 1997). For a review on membrane rafts in 
pathogen infection, see van der Goot and Harder, 2001 or Rosenberger et al., 2000. 
 
As mentioned above annexin A2 localises to membrane rafts. It plays an important role for the 
aggregation and stabilisation of these domains and probably functions by stabilising a lateral 
membrane segregation, i.e. that of raft and non-raft lipids (Gerke et al., 2005). Phosphatidylinositol-
4,5-bisphosphat (PI(4,5)P2) is a phospholipid component of cellular membranes which is localised to 
rafts (Pike and Casey, 1996). It has been reported that annexin A2 monomer and heterotetramer bind 
to PI(4,5)P2 with high specificity and affinity. This attachment is mediated by cationic residues at the 
convex side of the annexin A2 core domain, Lys279, Lys281 and Arg284 (Gokhale et al., 2005). The 
binding of annexin A2 to PI(4,5)P2 is linked to the organisation of actin at membrane sites that are 
enriched in this phospholipid (Rescher et al., 2004). Annexin A2 has also been described to be 
involved in the stabilisation and regulation of membrane microdomains at sites of dynamic actin 
rearrangement (Merrifield et al., 2001; Zobiack et al., 2002). 
In the presence of Ca2+ annexin A2 binds to and possibly promotes the lateral association of 
glycosphingolipid- and cholesterol-rich membrane microdomains (Babiychuk and Draeger, 2000; 
Harder and Gerke, 1994). Annexin A2 forms a monolayer of protein clusters when bound to a lipid 
bilayer (Menke et al., 2004). This lateral aggregation could promote the aggregation of membrane 
microdomains. Expression of a mutant annexin A2 protein causing the submembraneous aggregation 
of annexin A2 and its ligand p11 results in the simultaneous aggregation of a transmembrane raft 
protein (CD44) and a redirection of actin bundles towards these clusters (Oliferenko et al., 1999). 
Thus, due to its Ca2+-dependent membrane- and F-actin-binding and its intracellular location at sites of 
membrane rafts, annexin A2 could serve as an organiser of these membrane microdomains and their 
connection to the actin cytoskeleton (Gerke and Moss, 2002). 
A schematic model of the involvement of annexin A2 in membrane binding and membrane domain 
stabilisation is depicted in Figure 2-5. Annexin A2 might first be targeted to membranes by a general 
binding to negatively charged phospholipids and is then recruited to raft structures by the specific 
interaction with PI(4,5)P2. By engaging homophilic lateral interactions annexin A2 could then induce 
and/or stabilise raft clustering which is likely to be a prerequisite for actin assembly at such sites 
(Rescher et al., 2004). 
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Figure 2-5: Model of membrane domain stabilisation mediated by annexin A2 
The interaction of the heterotetrameric complex of annexin A2 (dark blue) and a p11 dimer (light blue) with 
membrane phospholipids might be mediated via the Ca2+-binding sites of the annexin A2 core domain (left). 
Lateral diffusion could then direct the complex to raft membrane domains enriched in cholesterol, 
glycosphingolipids and certain phosphatidylinositol phosphates, in particular PI(4,5)P2. Another fraction of 
annexin A2 heterotetramer might bind to raft lipids independently of Ca2+ (right). Lateral annexin-annexin 
interactions could lead to the formation of a protein scaffold beneath the membrane and the concomitant 
clustering of rafts and recruitment of F-actin. From Rescher and Gerke, 2004. 
2.2.2.4 Posttranslational modifications of annexin A2 
Annexin A2 was initially identified in 1980 as a substrate of the src kinase of Rous sarcoma virus (see 
2.2.1). The phosphorylation site has been localised to Tyr23 in the N-terminus. This phosphorylation 
alters some of the properties of the annexin A2 monomer and also of the heterotetramer. 
Phosphorylation on Tyr23 reduces the affinity of annexin A2 to phospholipids in liposome binding 
experiments (Powell and Glenney, 1987). In vitro phosphorylation of the annexin A2/p11 complex 
inhibits the ability of the protein to bind and bundle F-actin and to form a higher order complex 
together with the plasma membrane and secretory vesicles. Furthermore, an increased Ca2+ 
concentration is needed for vesicle aggregation by the phosphorylated complex (Hubaishy et al., 
1995). Annexin A2 is also phosphorylated on Tyr23 by the insulin receptor tyrosine kinase (Karasik et 
al., 1988) and by kinases associated with the platelet-derived growth factor (PDGF) (Brambilla et al., 
1991). 
Other phosphorylation sites of annexin A2 are Ser11 and Ser25 which are targeted by PKC (Johnsson 
et al., 1986; Jost and Gerke, 1996). Modification of Ser25 does not have an effect on the binding to 
lipids but it appears to be essential for annexin A2 function in Ca2+-regulated exocytosis (Sarafian et 
al., 1991). In vitro experiments suggest that phosphorylation of Ser11 can inhibit the formation of a 
complex between annexin A2 and p11 (Jost and Gerke, 1996). The phosphorylation of Ser11 and a 
resulting inhibition of complex formation can also be achieved by calmodulin- or cAMP-dependent 
kinases in vitro (Johnsson et al., 1986). 
Another posttranslational modification is the N-acetylation of annexin A2 which is of importance for the 
binding to p11 (Becker et al., 1990; Johnsson et al., 1988). 
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2.2.2.5 Annexin A2 and pathogens 
Annexins have been shown to be involved in the replication of several pathogens. It has been 
demonstrated that annexin A2 is incorporated into viral particles of the human immunodeficiency 
virus-1 (HIV-1) (Harrist et al., 2009). Further, there are several other enveloped viruses that 
incorporate annexin A2 as one of several host cell proteins into the virion. Annexin A2 was detected in 
extracellular and primary enveloped virions of herpes simplex virus 1 (Loret et al., 2008; Padula et al., 
2009) and in virions of vesicular stomatitis virus (Moerdyk-Schauwecker et al., 2009). Furthermore, 
this protein was identified in the viral particles of vaccinia virus (Chung et al., 2006), alcelaphine 
herpesvirus-1 (Dry et al., 2008; Zhu et al., 2005) and Kaposi’s sarcoma-associated herpesvirus (Zhu 
et al., 2005). Host cellular annexin A2 was also found to be associated with human cytomegalovirus 
(HCMV) (Wright et al., 1995). 
In most cases only the incorporation of annexin A2 and also other annexins was reported in the 
literature. Because annexins are calcium-dependent phospholipid-binding proteins and are proposed 
to act as scaffolding proteins at certain membrane domains their incorporation into virions might not 
just be accidental but those proteins might be important for viral infection cycles. The role of annexins 
in the viral replication remains rather elusive albeit a few exceptions. In HCMV annexin A2 is not only 
incorporated but it is also thought to act as a receptor for this virus on the surface of endothelial cells 
(Wright et al., 1994). Furthermore, this annexin has been shown to be a receptor for respiratory 
syncytial virus on epithelial cells (Malhotra et al., 2003). Annexin A2 plays a role in virus assembly in 
the case of HIV-1 (Ryzhova et al., 2006) and it facilitates HIV-1 binding to and entry into macrophages 
(Ma et al., 2004). A direct interaction of annexin A2 with HIV-GAG at GM1 containing membrane rafts 
in the plasma membrane of 293T cells has been demonstrated and in this cell line annexin A2 
increases the production of HIV-1 virus particles (Harrist et al., 2009). 
Enveloped viruses may use similar cellular pathways for their assembly and exit from the cell. But 
annexin A2 has also been described in the context of replication of other viruses. E.g. non-enveloped 
rabbit vesivirus particles have been shown to bind annexin A2. A monoclonal anti-annexin A2 antibody 
and siRNA-mediated knock-down of annexin A2 expression reduced the infection of this virus 
significantly (Gonzalez-Reyes et al., 2009). The non-structural protein 3 of bluetongue virus has been 
described to bind the annexin A2 binding partner p11. This interaction probably links the assembled 
virions to the cellular exocytic machinery (Beaton et al., 2002). 
Other annexins have also been reported to be essential for the pathogenesis of viruses. E.g. 
annexin A5 has been shown to specifically bind to a surface antigen of hepatitis B virus (HBV) and it 
was demonstrated that this protein is important for the susceptibility of cells to HBV infection (Gong et 
al., 1999; Hertogs et al., 1993). In a fish cell line salmon annexin A1 transcription is induced after 
infection of the cells with the non-enveloped RNA virus infectious pancreatic necrosis virus and the 
depletion of this annexin leads to a reduction of the virus titre (Hwang et al., 2007). 
Involvements of annexins in pathogen replication are very diverse and are not limited to viruses. E.g. 
annexin A2 has been described to act as a receptor for Pseudomonas aeruginosa (Kirschnek et al., 
2005) and it is of importance for the F-actin aggregation underneath some E. coli strains during the 
course of infection (Miyahara et al., 2009; Zobiack et al., 2002). Furthermore, annexin A2 is involved in 
microbial clearance by macrophages (Swisher et al., 2007). 
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2.3 Aim of this thesis 
The cellular mechanisms that are important for IAV replication are rather nondistinctive and a better 
understanding could help in finding strategies to fight this pathogen. The focus of this work thereby 
was to elucidate a possible role of host cell annexin A2 in influenza A infection. Annexin A2 as a 
candidate host factor in IAV replication was chosen for several reasons. First, annexin A2 was 
identified as a structural component of membrane rafts that is involved in the aggregation and 
stabilisation of these domains. Since membrane rafts have been defined as the budding site of IAV, 
annexin A2 could be involved in IAV replication, specifically virus budding. Second, annexin A2 is 
involved in several endo- and exocytotic processes and is especially important for the apical transport 
of raft associated proteins. Such annexin A2-regulated transport processes might also be crucial for 
efficient influenza A replication. Third, annexin A2 is involved in actin dynamics and the organisation of 
the actin cytoskeleton is of importance for influenza A replication. 
To elucidate a possible role of annexin A2 in influenza A infection the replication of IAV and the 
surface localisation of influenza HA were determined in annexin A2 manipulated cells. Furthermore, a 
possible incorporation of this protein into the virion was analysed and the localisation of IAV in infected 
host cells was visualised with respect to a possible colocalisation with annexin A2. 
 
A second focus of this work was placed on the association of annexin A2 with membrane rafts. 
Particularly the effects of posttranslational modifications and ligand binding to annexin A2 on the raft 
association of this protein were investigated. Therefore, cellular annexin A2 phosphorylated on Tyr23 
as well as ectopically expressed phospho-deficient and phospho-mimicking mutants of annexin A2 
were analysed for the association with detergent resistant membranes (DRMs) as a defining criterion 
for membrane rafts. Furthermore, ectopically expressed proteins harbouring mutations in either the 
PI(4,5)P2-binding site, the high affinity Ca2+-binding sites or the p11-binding site were analysed. This 
analysis included the recruitment of the different annexin A2 variants to GM1 membrane phases and 
the recording of membrane order in regions of annexin A2 localisation with the help of Laurdan 
2-photon microscopy. 
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3 Materials and Methods 
3.1 Materials 
3.1.1 Virus strains 
FPV: avian influenza virus A/Bratislava/79 (H7N7); from Stephan Pleschka, Gießen, Germany 
 
PR8: human influenza A/Puerto-Rico/8/34 (H1N1); from Thorsten Wolff, Berlin, Germany 
 
3.1.2 Bacterial strains 
E. coli DH5: a chemically competent derivative of the E. coli strain K-12 used for plasmid 
amplification 
 
3.1.3 Eukaryotic cell lines 
A431: human epithelial skin cells from an epidermoid carcinoma, enriched in GM1; 
from Daniel Lingwood, Dresden, Germany 
 
A549: human epithelial lung carcinoma cell line; from Stephan Ludwig, Münster, 
Germany 
 
BHK-IR: baby hamster kidney cells stably overexpressing the human insulin receptor 
(IR); from Axel Ullrich, Martinsried, Germany 
 
CMEC: cardiac microvascular endothelial cells isolated from a wt mouse (C57Bl/6J) 
(anxA2+/+) or the annexin A2 knockout mouse (anxA2-/-); from Katherine A. 
Hajjar, New York, USA (Ling et al., 2004) 
 
HeLa: human epithelial cell line derived from a cervical cancer 
 
HepG2: human epithelial cell line derived from a hepatocellular carcinoma 
 
MDCK II: Madin Darby canine kidney: epithelial cell line derived from a kidney of a 
female cocker spaniel by S.H. Madin and N.B. Darby 
 
    MDCK-anxA2-GFP: MDCK II cell line stably expressing GFP labelled annexin A2; from 
Fernando Martín-Belmonte, San Francisco, USA (Martin-Belmonte et al., 
2007) 
 
    MDCK-IMV: MDCK II cell line used for virus infections and plaque assays; from Stephan 
Ludwig, Münster, Germany 
 
    MDCK-Tet: MDCK II cell line able to polarise on filters and form cysts; this cell line was 
used for the DRM association analysis of annexin A2 mutants 
 
    MDCK-TG: MDCK II cell line used in the lab of Thomas Grewal, Sydney, Australia 
 
    MDCK-XM: MDCK II cell line expressing the XM protein. The expression of this protein 
is regulated by a tet-off transactivator type II (Clontech, Germany) (Harder 
and Gerke, 1993) 
 
 
Materials and Methods 17
3.1.4 Plasmids 
anxA2-GFP: pEGFP-N3 vector (Clontech) coding for human annexin A2 fused with GFP 
under the control of a CMV promoter. The sequence of annexin A2 contains 
the aa exchange A65E allowing the specific detection of this ectopically 
expressed protein with the monoclonal antibody H28. 
 
anxA2 YE-GFP: pEGFP-N3 vector coding for human annexin A2 fused with GFP under the 
control of a CMV promoter. The sequence of annexin A2 contains the aa 
exchange Y23E. The addition of negative charge mimics the phosphorylation 
of Tyr23 (Rescher et al., 2008). The sequence also contains the aa 
substitution A65E (see above). 
 
anxA2 YF-GFP: pEGFP-N3 vector coding for human annexin A2 fused with GFP under the 
control of a CMV promoter. The sequence of annexin A2 contains the aa 
exchange Y23F. This exchange makes the phosphorylation of aa 23 
impossible (phosphorylation deficient). The sequence also contains the aa 
substitution A65E (see above). 
 
anxA2 KA-GFP: pEGFP-N3 vector coding for human annexin A2 fused with GFP under the 
control of a CMV promoter. The sequence of annexin A2 contains the aa 
exchange K281A. This exchange leads to a deficiency in binding to PI(4,5)P2 
in vitro (Gokhale et al., 2005). The sequence also contains the aa substitution 
A65E (see above). 
 
anxA2 PM-GFP: pEGFP-N3 vector coding for human annexin A2 fused with GFP under the 
control of a CMV promoter. The sequence of annexin A2 contains the aa 
exchanges I6E and L7E in the p11-binding site, rendering this protein unable 
to bind p11 (Thiel et al., 1992). The sequence also contains the aa 
substitution A65E (see above). 
 
anxA2 CM-GFP: pEGFP-N3 vector coding for human annexin A2 fused with GFP under the 
control of a CMV promoter. The sequence of annexin A2 contains the aa 
exchanges D161A, E246A and D321A which inactivate the type II Ca2+-
binding sites (Jost et al., 1992). The sequence also contains the aa 
substitution A65E (see above). 
 
anxA2 PMCM-GFP: pEGFP-N3 vector coding for human annexin A2 fused with GFP under the 
control of a CMV promoter. The sequence of annexin A2 contains the aa 
exchanges I6E, L7E, D161A, E246A and D321A. So this protein harbours 
inactive p11- and type II Ca2+-binding sites (Jost et al., 1997). The sequence 
also contains the aa substitution A65E (see above). 
 
GFP: pEGFP-N3 vector coding for the GFP-tag under the control of a CMV 
promoter. 
 
pRSET-B mCherry: 
 
pRSET-B vector (Invitrogen) coding for an mCherry tag. From Roger Y. Tsien, 
San Diego, USA. 
 
anxA2 xx-mCherry: pEGFP-N3 vector coding for annexin A2 constructs (xx: wt, YE, YF, KA, PM, 
PMCM) under the control of a CMV promoter. The GFP-tag has been 
substituted by mCherry (see 3.4.4). 
 
mCherry: 
 
pEGFP-N3 vector coding for mCherry instead of EGFP under the control of a 
CMV promoter. 
 
H7-HA: pCAGGS vector expressing the HA of IAV A/FPV/Rostock/34 (H7N1) (Marjuki 
et al., 2006). From Stephan Pleschka, Giessen, Germany. 
 
PHD-YFP: pEYFP-N1 vector (Clontech) coding for the PHD of human PLC-1 (Rescher 
et al., 2004). 
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3.1.5 Oligonucleotides 
Oligonucleotides were purchased from Sigma Proligo, if not indicated otherwise. 
 
Oligonucleotides for siRNA mediated knock-down of proteins 
 
anxA2 (2.3) fwd: 5’ CUUUGAUGCUGAGCGGGAU 3’ 
rev: 5´ AUCCCGCUCAGCAUCAAAG 3´  
siRNA duplex corresponding to 
nucleotides 94 - 113 of the coding 
sequence from human annexin A2 
 
control  non-targeting siRNA (Dharmacon)  
 
 
Oligonucleotides for real-time PCR analysis 
 
M1 fwd: 5’ AGATGAGTCTTCTAACCGAGGTCG 3’ 
rev: 5’ TGCAAAAACATCTTCAAGTCTCTG 3’ 
 
annexin A1 Hs_ANXA1_1_SG QuantiTect Primer Assay (Qiagen) 
 
annexin A2 Hs_ANXA2_1_SG QuantiTect Primer Assay (Qiagen) 
 
GAPDH Hs_GAPDH_2_SG QuantiTect Primer Assay (Qiagen) 
 
 
Oligonucleotides for sequencing 
 
pEGFP-N.3’.2 5’ CGCTGAACTTGTGGCCGT 3’ 
 
 
Oligonucleotides for PCR amplification 
 
mCherry fwd: 5’ GATCGCGGCCGCTTACTTGTACAGCTCGTC 3’ 
rev: 5’ GATCGGATCCGCCACCATGGTGAGCAAG 3’ 
 
3.1.6 Enzymes 
BamH I MBI Fermentas 
GoTaq® Promega 
Not I MBI Fermentas 
Pfu Turbo DNA polymerase Stratagene 
Sac I MBI Fermentas 
T4 DNA ligase MBI Fermentas 
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3.1.7 Antibodies 
Primary antibodies 
dilution 
 
  
 
antigen 
 
host 
 
origin WB IF FACS
      
annexin A2 (HH7) Ms Thiel et al., 1992 1:5000 1:100  
annexin A2 (H28) Ms Osborn et al., 1988  1:100  
annexin A2 Ms BD Transduction Lab 1:5000   
caveolin Rb BD Transduction Lab 1:5000   
cleaved caspase-8 Rb Cell Signaling 1:1000   
cleaved caspase-9 Rb Cell Signaling 1:1000   
GFP Ms Clontech 1:1000   
H7-HA Ms Marjuki et al., 2006   1:100 
H7-HA (2KP 96/11) Rb Marjuki et al., 2006  1:200  
M1 Ms AbD Serotech 1:1000   
NS1 (23-1) Ms Ehrhardt et al., 2007 1:500   
p11 (H21) Ms Osborn et al., 1988 1:1000 1:300  
PARP Ms BD Transduction Lab 1:500   
pTyr (4G10® platinum) Ms Millipore 1:1000   
human transferrin receptor (H68.4) Ms Zymed 1:3000   
vimentin Ms Dianova 1:500   
 
Secondary antibodies 
dilution 
   
 
antigen 
 
species 
 
label 
 
origin WB IF FACS 
       
Ms Rb POX Dako 1:2000   
Ms G TxRed Dianova  1:200  
Ms G Cy2 Dianova  1:300  
Rb G POX Dako 1:5000   
Rb G Alexa568 Invitrogen  1:500  
Rb G FITC Dianova   1:300 
3.1.8 Kits 
BigDye® Terminator Cycle Sequencing Kit Applied Biosystems 
Gene Elute Plasmid Miniprep Kit Sigma 
High-Capacity cDNA Reverse Transcription Kit Applied Biosystems 
JetStar Maxi Kit Genomed 
PCR Purification Kit Qiagen 
Platinum® SYBR® Green qPCR SuperMix UDG with ROX Invitrogen 
QIAquick Gel Extraction Kit Qiagen 
RNeasy Mini Kit Qiagen 
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3.1.9 Chemicals and reagents 
10 x MEM Gibco  
2-mercaptoethanol Roth 
7.5 % NaHCO3 Gibco 
acrylamid / methylenbisacrylamid (30 % / 0.8 %) Roth 
agar Oxoid 
agarose Biozym Diagnnostic GMBH 
Amersham ECL Plus™ Western Blotting Detection Reagent GE healthcare 
ampicillin Sigma-Aldrich 
APS Roth 
blasticidin Invitrogen 
bovine albumin 35% MP Biomedicals 
bromophenol blue Amresco 
BSA fraction V Roche 
CtxB Alexa Fluor® 594 conjugate Molecular Probes 
Coomassie (Bradford) Protein Assay Kit Thermo Scientific 
cycloheximide Fluka 
DEAE dextran Roth 
DNA molecular weight standard: 1 kb DNA ladder  MBI Fermentas 
dNTPs MBI Fermentas 
Dulbecco’s MEM  PAA Laboratories GmbH 
Dulbecco’s PBS  PAA Laboratories GmbH 
EDTA AppliChem 
ethidiumbromide Sigma 
FCS PAA Laboratories GmbH 
glucose Sigma 
insulin Sigma-Aldrich 
kanamycin AppliChem 
L-glutamine Cambrex 
Laurdan Invitrogen 
LipofectamineTM 2000 Invitrogen 
loading dye MBI Fermentas 
luminol Roth 
MEM PAA Laboratories GmbH 
Mowiol® 4-88 Calbiochem 
neutral red Sigma 
n-propyl gallate Sigma 
OligofectamineTM Invitrogen 
Opti-MEM®  Invitrogen 
p-coumaric acid Roth 
penicillin / streptomycin Cambrex  
PFA Merck 
PIC (complete, EDTA-free) Roche 
prestained protein marker, broad range NEB 
saccharose AppliChem 
SDS pellets Roth 
skimmed milk powder AppliChem 
staurosporine Sigma 
Surfact-Amps X-100 Thermo Scientific 
TEMED Sigma 
TNF PeproTech (tebu-bio) 
transferrin FITC Invitrogen 
trypsin/EDTA Biochrom 
trypsin SOLO Gibco BRL 
trypan blue Sigma 
 
All other chemicals were purchased from Roth, Merck or Sigma-Aldrich. 
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3.1.10 Other materials and equipment 
ABIPrism® 7900 HT Applied Biosystems 
BioPhotometer Eppendorf 
blotting paper Hartenstein 
Branson Sonifier® 250 G. Heinemann 
cell culture dishes Greiner Bio-One 
centrifuges and rotors  
    Biofuge Fresco Heraeus 
    Biofuge Pico Heraeus 
    Megafuge 1.0R Heraeus 
    Centrifuge C5810R Eppendorf 
    Centrifuge 5417R Eppendorf 
    OptimaTM L-70K ultracentrifuge G. Heinemann 
      rotor SW60 Ti Beckman 
      rotor SW41 Ti Beckman 
confocal microscope LSM510 Meta Zeiss 
    heating insert P Zeiss 
    objective heater Zeiss 
confocal microscope TCS SP5  Leica 
    Mai Tai , mode-locked Ti:Sapphire laser ® Spectra-Physics 
developing machine CURIX60 Agfa 
developing reagents: developer and rapid fixer Agfa 
electrophoresis chamber PeqLab 
EOS 350D Canon 
FACSCaliburTM BD 
FACSFlowTM BD 
ImmobilonTM-P PVDF membrane Millipore 
incubators Memmert 
incubators for cell culture Heraeus 
inverted microscope Axiovert 40 C  Zeiss 
inverted microscope Leica DM IL Leica 
Lab-TekTM chamber coverglass Nunc 
laboratory shaker Innova 4000 New Brunswick Scientific 
laminar flow BDK 
Mini-Trans-Blot chamber BioRad 
MultiphorTM II Electrophoresis unit  Amersham Biosciences 
petri dishes Corning 
refractometer Zeiss 
spectrophotometer DU®-640 Beckman 
thermocycler TRIO heated lid Biometra 
UV-transluminator Biometra 
X-ray films Fuji Super RX, 13 x 18 cm Fischer-Sehner 
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3.2 Cellbiological methods 
3.2.1 Cell culture 
MDCK-IMV were cultivated in MEM supplemented with 10 % heat inactivated FCS, penicillin, 
streptomycin and glutamine at 37 °C and 5 % CO . All other cell lines were grown in supplemented 
DMEM at 7 % CO . For the cultivation of MDCK-XM tetracycline (1 µg/ml) was added unless the 
expression of the XM protein was desired. When cultivating MDCK-anxA2-GFP the medium was 
supplemented with blasticidin (50 µg/ml). 
2
2
When reaching confluency the cells were washed with PBS without Ca  and Mg  and detached from 
the cell culture dish by incubating with trypsin/EDTA solution (0.05 % trypsin, 0.2 % EDTA) at 37 °C 
for several minutes. When using MDCK cells after the first wash step PBS was added and the cells 
were incubated for 10 min at 37 °C before trypsinisation. As soon as the cells detached from the cell 
culture dish they were collected in fresh medium to inactivate trypsin and centrifuged at 800 rpm for 
4 min (Megafuge 1.OR; rotor 7750). The resulting pellet was resuspended in fresh supplemented 
medium and the cell number and viability were determined by counting trypan blue stained cells in a 
haemocytometer. The cells were seeded in an appropriate ratio onto new cell culture dishes. 
2+ 2+
3.2.2 Freezing cells 
To freeze cells for long term storage the cells of a subconfluent 10 cm cell culture dish were 
trypsinised and afterwards pelleted via centrifugation. The pellet was resuspended in 1 ml of chilled 
freezing-medium (10 % DMSO in FCS). The cells were frozen at -80 °C for several days before 
transferring them into liquid nitrogen. 
3.2.3 Thawing cells 
Cells were thawed quickly at 37 °C and transferred into pre-warmed media. After centrifugation the 
supernatant was discarded and the cells were resuspended in 1 ml medium before being transferred 
into a culture dish containing the appropriate amount of media. The cells were cultivated as described 
above (see 3.2.1). 
3.2.4 Transient transfection of eukaryotic cells 
3.2.4.1 Plasmid transfection 
To deliver plasmid DNA into A431 cells transient transfections were carried out using 
Lipofectamine 2000 according to the manufacturer’s protocol. MDCK and A549 were transfected by 
means of a modified transfection protocol using Lipofectamine 2000 to yield higher transfection 
efficiencies. For this protocol the adherent cell lines were transfected in suspension. The transfection 
of one 35 mm dish is depicted in the following. 
Cells were detached from the cell culture dish via trypsinisation and counted. 2*106 cells were 
resuspended in 1.5 ml DMEM without antibiotics. In the meantime 2 µg DNA were diluted in 50 µl 
OptiMEM and 10 µl Lipofectamine 2000 in 200 µl OptiMEM. After vortexing and 5 min incubation at RT 
the two dilutions were mixed, vortexed and incubated for additional 15 min. The cells were transferred 
to a cell culture dish and the DNA/Lipofectamine mixture was added. After incubation for 4 - 6 h at 
37 °C and 7 % CO2 the medium was changed. 
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3.2.4.2 siRNA transfection 
siRNA transfection of A549 was performed using Lipofectamine 2000 according to the manufacturer’s 
instructions. 
When transfecting siRNA into HeLa cells Oligofectamine was used. Cells were seeded in a 35 mm cell 
culture dish and grown to about 50 % confluency. 100 pmol siRNA were diluted in 175 µl DMEM 
without antibiotics and 4 µl Oligofectamine was mixed with 11 µl antibiotic-free medium. After 
incubation for 5 - 10 min at RT the two dilutions were mixed and incubated for 20 min. In the meantime 
800 µl of fresh antibiotic-free DMEM was added to the cells. The siRNA/Olicofectamine mixture was 
added and the cells were cultivated for 3 - 4 h. 1 ml of complete DMEM was added and the cells were 
further cultivated at 37 °C and 7 % CO2 for 48 h. 
3.2.5 Immunofluorescence 
Cells cultivated on coverslips were washed with PBS before being fixed with 10 % FA in PBS for 
10 min at RT. The cells were washed for 5 min with PBS under gentle rocking and permeabilised by 
incubation with 0.2 % Triton X-100 in PBS for 2 min. After a washing step the free aldehyde groups of 
FA were quenched by incubation with 50 mM NH4Cl for 7 min. 
Before antibody incubation the fixed cells were blocked for 30 - 60 min with 2 % BSA in PBS. 
Incubation with the primary antibody was performed for 1 h at RT. After washing the cells with PBS 
they were incubated with an appropriate fluorophore labelled secondary antibody for 1 h. The 
antibodies were diluted in 2 % (w/v) BSA in PBS. After extensive washing the coverslips were rinsed in 
dist. H2O and mounted onto microscope slides in Mowiol containing 4 % n-propyl gallate as anti-fading 
reagent. Microscopy images were obtained with an LSM510 Meta confocal microscope equipped with 
a Plan-Apochromat 63x/1.4 oil immersion objective. 
 
PBS 
137 mM NaCl 
2.68 mM KCl 
8.1 mM Na2HPO4 
1.47 mM KH2PO4 
pH 7.4 
3.2.6 Induction and microscopy of PMSs 
Plasma membrane spheres (PMSs) were prepared according to Lingwood et al., 2008. A431 cells 
were seeded on Lab-Tek chamber slides and transfected with GFP labelled constructs one day 
afterwards (3.2.4.1). Two days after seeding the cells were washed with PBS and incubated overnight 
with PMS buffer. Phase separation of the PMSs was induced by clustering GM1 with 1 µg/ml CtxB 
Alexa Fluor 594 conjugate for at least 2 h at 37 °C. The distribution of transferrin receptor was 
evaluated by the incubation of the phase separated PMSs of untransfected cells with 10 µg/ml FITC 
labelled transferrin for 1 h at 37 °C. Excess transferrin was removed by changing the PMS buffer to 
reduce background staining. For imaging the PMSs using the LSM510 Meta confocal microscope a life 
cell setup was used. The temperature was maintained at 37 °C by using a heating chamber, an 
objective heater and temperature controllers. 
 
Materials and Methods 24
PMS buffer  
1.5 mM CaCl2 
1.5 mM MgCl2 
5 mM Hepes 
1 mg/ml Glucose 
in PBS pH 7.4 
3.2.7 Laurdan 2-photon microscopy 
3.2.7.1 Tissue culture for microscopy 
0.2*106 MDCK-TG were plated on coverslips in a 35 mm tissue culture dish. The next day the cells 
were transfected with mCherry-tagged annexin A2 constructs using Lipofectamine 2000 according to 
the manufacturer’s instructions. 24 h afterwards the cells were washed once with warm PBS and 
incubated with 5 µM Laurdan in 1 ml serum-free medium for 30 min at 37 °C. After washing the cells 
twice with warm PBS they were fixed with 4 % PFA for 20 min at RT. After washing with PBS the 
coverslips were rinsed in dist. H2O and mounted in Mowiol. 
3.2.7.2 Microscopy 
Microscopy images were obtained with a TCS SP5 microscope using a 63 x oil immersion objective. 
Laurdan fluorescence was excited at 800 nm with a Mai Tai, mode-locked Ti:Sapphire laser and 
intensity images were recorded simultaneously in the range of 400 - 460 nm and 470 - 530 nm for the 
two channels, respectively. For confocal microscopy, mCherry fluorescence was excited at 561 nm 
and the emission was recorded at 570 - 630 nm. The microscopy was performed in the laboratory of 
Katharina Gaus, University of New South Wales, Sydney, Australia. 
3.2.7.3 Image analysis 
Using the two Laurdan intensity images GP values were calculated for each pixel with the software 
Image J using a plug-in written by Carles Rentero, Sydney, Australia. GP values were corrected by 
using the G-factor obtained for Laurdan in DMSO. GP images were pseudo-coloured in Adobe 
Photoshop. 
The confocal fluorescence images of mCherry tagged annexin A2 wt and mutant proteins were used 
to identify the localisation of these proteins in liquid-disordered / liquid-ordered (low / high GP value) 
regions, respectively. To do so, areas of high mCherry fluorescence were used to define a mask in 
Adobe Photoshop. This mask was layered onto the GP image to selectively determine the GP values 
of the regions of fluorophore localisation. 
3.2.8 Flow cytometry 
The hemagglutinin surface localisation in A549 was determined via flow cytometric measurements 
(Marjuki et al., 2006). For each measurement the cells of one 35 mm dish were used and samples 
were prepared in duplicate. A549 were transfected with an HA expressing plasmid (3.2.4.1). 24 h later 
the cells were detached with trypsin/EDTA, transferred into DMEM and centrifuged at 5 000 rpm for 
4 min at 4 °C (Biofuge Fresco). After washing with PBS the cell pellet was fixed with 4 % FA in PBS 
for 1 h at RT. The cells were washed with PBS and stepwise incubated with MsH7-HA (1:100) and 
then with RbMs FITC-conjugated antibody for 30 min on ice each. The cells were washed between 
Materials and Methods 25
and after the antibody incubation steps with cold PBS and finally resuspended in PBS to determine the 
HA surface localisation by FACS analysis. 
3.3 Proteinbiochemical methods 
3.3.1 Preparation of cellular protein extracts 
Cells were washed with cold PBS, scraped off the cell culture dish in PBS and transferred into a 
reaction tube. After centrifugation at 13 000 rpm for 1 min at 4 °C (Biofuge Fresco) the cell pellet was 
resuspended in an appropriate volume of 8 M urea and sonified on ice (2 pulses, output control: 50 %, 
amplitude control: 5).  
3.3.2 Triton solubilisation 
The isolation of detergent resistant membranes (DRMs) was performed according to Brown and Rose, 
1992. The cells of one 80 - 90 % confluent 35 mm cell culture dish were washed once with ice cold 
PBS, scraped in 1 ml PBS and transferred into a reaction tube. The tube was spun for 5 min at 2 000 
rpm at 4 °C (Biofuge Fresco) and the cell pellet was resuspended in 200 µl cold MES buffer. The cells 
were homogenised by squeezing them through a 22-gauge needle ten times on ice. After incubation 
for 20 min on ice the homogenised cells were centrifuged for 20 min at 14 000 rpm and 4 °C. The 
supernatant contains the Triton soluble proteins and was transferred into a new reaction tube. The 
Triton insoluble pellet was solubilised in 50 µl HEPES buffer for 30 min at RT. The CaCl2 
concentrations added to the buffers varied in the different experiments and are indicated in the 
respective captions. 
 
MES buffer 
25 mM MES pH 6.5 
0.15 M NaCl 
1 % (v/v)Triton X-100 final (Surfact-Amps X-100) 
PIC 
HEPES buffer 
25 mM HEPES pH 7.4 
0.15 M NaCl 
1 % (v/v) Triton X-100 final (Surfact-Amps X-100) 
PIC 
3.3.3 DRM flotation gradient 
The cells of one 80 - 90 % confluent 10 cm dish were washed with ice cold PBS and scraped in 1 ml 
PBS into a reaction tube. The cells were spun down for 5 min at 2 000 rpm at 4 °C (Biofuge Fresco), 
resuspended in 1 ml lysis buffer and disrupted by sonification on ice (20 pulses, output control: 50 %, 
amplitude control: 5). Nuclear remnants and ER were removed with a centrifugation step (10 min, 
2 000 rpm, 4 °C). The supernatant was adjusted to 7 ml and transferred into an ultracentrifugation 
tube. Membranes were sedimented by centrifugation for 30 min, 150 000 g at 4 °C (rotor SW41 Ti) 
and homogenised in 1 ml Triton buffer by squeezing through a 20-gauge needle twenty times on ice. 
After incubation for 30 min at 4 °C the pellet was homogenised again with a 20-gauge needle. 
Following 30 min incubation on ice the homogenisation step was repeated a third time. After another 
30 min incubation step on ice the resuspended membranes were brought to 42 % saccharose by the 
addition of 85 % saccharose. The percentage of the saccharose was checked in a refractometer. The 
membrane dilution was overlayed with 8 ml 30 % saccharose solution and 2 ml 5 % saccharose 
solution and centrifuged at 200 000 g for 19 h at 4 °C. 1.5 ml fractions were collected from the top. 
The proteins were concentrated via TCA precipitation (3.3.5). 
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lysis buffer 
10 mM HEPES pH 7.4 
42 mM KCl 
5 mM MgCl2 
50 µM CaCl2 
PIC 
 
TN 
10 mM Tris pH 7.5 
150 mM NaCl 
50 µM CaCl2 
Triton buffer 
1 % (v/v) Triton X-100 final (Surfact-Amps X-100) 
in TN  
saccharose solutions 
85% (w/v) saccharose in TN 
30% (w/v) saccharose in TN 
5% (w/v) saccharose in TN 
3.3.4 Protein quantification 
Protein concentrations were determined with the Bradford protein assay (Bradford, 1976). The protein 
solution was diluted 1:500 in 500 µl dist. H2O and incubated with 500 µl Coomassie Plus Protein 
Assay Reagent for 15 min at RT. The absorbance was measured at 595 nm with a spectrophotometer 
(DU®-640). A BSA standard curve (0 - 10 µg) was used to calculate the unknown protein 
concentration. 
3.3.5 Protein precipitation with TCA 
To concentrate proteins they were precipitated with TCA. 100 % TCA was added to the protein 
solution to give a final TCA concentration of 15 % and the solution was frozen at -20 °C for 1 h. After 
thawing on ice the proteins were precipitated by a 20 min centrifugation step at 13 000 rpm at 4 °C 
(Biofuge Fresco). The resultant protein pellet was washed with 2 % (w/v) sodium acetate in 70 % 
ethanol and after centrifugation the pellet was air-dried. The proteins were resuspended in SDS 
sample buffer and used for western blot analysis (3.3.7). 
3.3.6 SDS-PAGE 
Separation of proteins according to their apparent molecular mass was performed by denaturing 
sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) according to Laemmli, 1970. 
Depending on the molecular weight of the proteins resolving gels with polyacrylamide concentrations 
of 10 % or 12 % (v/v) were used. For each sample 30 µg protein was denatured in SDS sample buffer 
by boiling for 5 min at 95 °C prior to loading on an SDS-polyacrylamide gel (SDS-PAG). As a 
molecular weight standard Prestained Protein Marker was used. Separation was performed with 
15 mA in the stacking gel and 30 mA in the resolving gel until the bromophenol blue dye front reached 
the desired height. The proteins were visualised via western blot analysis (3.3.7). 
 
10 % / 12 % resolving gel 
33 % / 40 % (v/v) acrylamid / methylenbisacrylamid 
375 mM Tris pH 8.8 
0.1 % (w/v) SDS 
0.1 % (w/v) APS 
0.0004 % (v/v) TEMED 
5 % stacking gel 
17 % (v/v) acrylamid / methylenbisacrylamid  
125 mM Tris pH 6.8 
0.1 % (w/v) SDS 
0.1 % (w/v) APS 
0.001 % (v/v) TEMED 
 
running buffer 
25 mM Tris 
0.1 % (w/v) SDS 
192 mM glycine 
4 x SDS sample buffer 
250 mM Tris pH 6.8 
40 % (v/v) glycerine 
1.5 % (w/v) SDS 
2 % (v/v) 2-mercaptoethanol 
0.3 mM bromophenol blue 
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3.3.7 Western blotting 
For immunoblot analysis the proteins were first separated on an SDS-PAG (3.3.6) and afterwards 
transferred onto a PVDF membrane where they could be detected by means of specific antibodies. 
The membrane was activated and equilibrated according to the manufacturer’s instructions. The PAG 
and the membrane were arranged in a tank blot chamber filled with transfer buffer. The proteins were 
transferred onto the membrane in an electric field of 300 mA for 1 h while cooling with ice. 
To reduce unspecific antibody binding the PVDF membrane was blocked for 1 h with blocking buffer 
(either 5 % BSA in TBS-T or 5 % skim milk powder in TBS-T, depending on the primary antibody) at 
RT. The membrane was washed with TBS-T before being incubated with the primary antibody 
overnight at 4 °C under gentle rocking. After washing three times for 10 min with TBS-T the membrane 
was incubated with the appropriate peroxidase coupled secondary antibody for 1 h at RT. The primary 
as well as the secondary antibody was diluted in blocking buffer. Afterwards the membrane was 
washed three times with TBS-T. For the detection of the proteins the blot was incubated with self 
made ECL solution for 2 min. For the detection of weak signals Amersham ECL Plus™ Western 
Blotting Detection Reagent was used according to manufacturer’s protocol. The incubation with the 
ECL reagent was followed by immediate exposure of the blot to on an X-ray film. 
 
transfer buffer 
50 mM Tris 
50 mM boric acid 
 
TBS-T 
20 mM Tris pH 7.5 
150 mM NaCl 
0.2 % (v/v) Tween 20 
 
self made ECL solution 
2.5 mM luminol 
0.4 mM p-coumaric acid  
100 mM Tris pH 8.5 
0.0175 % H2O2 (added immediately before use) 
3.3.8 Stripping of blot membranes 
For re-probing of membranes former immunocomplexes were removed by incubation of the 
membrane in stripping buffer for 30 min at 50 °C. Afterwards the membrane was washed with TBS-T 
before incubation with the blocking reagent and antibodies. 
 
stripping buffer 
62.5 mM Tris pH 6.5 
2 % (w/v) SDS 
100 mM 2-mercaptoethanol 
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3.4 Molecular biological methods 
3.4.1 Bacterial methods 
3.4.1.1 Cultivation and long term storage of bacteria 
Bacteria were cultivated in liquid LB medium at 37 °C under permanent agitation of 250 rpm or plated 
on solid agar plates which were incubated at 37 °C. For selection of transformed bacteria, media or 
agar plates were supplemented with appropriate antibodies (100 µg/ml ampicillin or 30 µg/ml 
kanamycin). For long-term storage, glycerol was added to the bacterial suspension to a final 
concentration of 12.5 % (v/v) and the culture was frozen at -80 °C. 
 
LB medium 
1 % (w/v) tryptone 
0.5 % (w/v) yeast extract 
0.5 % (w/v) NaCl 
[1.2 % (w/v) agar for solid medium] 
pH 7.0 
3.4.1.2 Preparation of CaCl2-competent E. coli DH5 
To prepare heat shock competent E. coli DH5 an overnight culture was diluted 1:50 in 50 ml LB 
medium and cells were grown at 37 °C at 250 rpm until the cell suspension reached an OD600nm 
= 0.3 - 0.4. Then, the bacteria were spun down (10 min, 4 °C, 2 500 rpm, Heraeus Megafuge 1.OR) 
and the resultant pellet was resuspended in 40 ml ice cold 100 mM CaCl2 solution. Following 30 min 
incubation on ice, cells were again pelleted and resuspended in 2 ml CaCl2 supplemented with 20 % 
(v/v) glycerol. 50 µl aliquots of this cell suspension were frozen in liquid nitrogen and stored at -80 °C 
until use. 
3.4.1.3 Transformation of CaCl2 competent E. coli DH5 
50 µl CaCl2 competent E. coli were slowly thawed on ice. 1 µg DNA or 1 µl ligation mixture were 
added and the cells were incubated for 30 min on ice. Afterwards the bacteria were exposed to a heat 
shock (1 min 42 °C) and regenerated on ice for 5 min. 1 ml antibiotic-free LB medium was added and 
the cells were incubated at 37 °C for 1 h under gentle agitation. For selection transformed bacteria 
were plated on LB agar plates containing the appropriate antibiotic and incubated overnight at 37 °C. 
3.4.2 Methods of DNA preparation 
3.4.2.1 Isolation and determination of plasmid DNA 
For small scale isolation of plasmid DNA of a 2 ml overnight bacterial culture the Gene Elute Plasmid 
Miniprep Kit was used according to the manufacturer’s instructions. For the isolation of larger amounts 
of DNA from a 200 ml overnight culture the JetStar Maxi Kit was used. 
DNA concentration was determined by measuring the OD260nm using the Eppendorf BioPhotometer. 
An OD260nm of 1.0 accords to 50 μg/ml DNA. 
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3.4.2.2 Agarose gel electrophoresis 
1 % (w/v) agarose were dissolved in 1 x TAE buffer by boiling and supplemented with 0.5 µg/ml 
ethidium bromide for DNA detection. The DNA samples were mixed with 6 x sample buffer and loaded 
together with an appropriate molecular weight marker onto the gel. Electrophoresis was carried out at 
80 - 150 V and separated fragments were visualised by exposure to UV light ( = 320 nm) on a 
transilluminator. 
 
1 x TAE  
40 mM Tris pH 8.0 
40 mM glacial acetic acid 
1 mM EDTA 
3.4.2.3 Elution of DNA from agarose gels 
The DNA was separated on an agarose gel and visualised using ethidium bromide (3.4.2.2). The 
appropriate band was cut out of the gel and the DNA was isolated using the QIAquick Gel Extraction 
Kit according to the manufacturer’s protocol. 
3.4.3 Enzymatic DNA methods 
3.4.3.1 Restriction digests 
For analytical restriction digests the DNA was incubated with specific enzymes in an appropriate buffer 
for 1 - 2 h at 37 °C. The used enzyme amount was calculated on the basis of -DNA reference 
restriction. The reaction buffer was chosen according to manufacturer’s recommendation. Following 
incubation, restriction enzymes were heat-inactivated for 20 min at 80 °C and the restriction pattern 
was examined by agarose gel electrophoresis (3.4.2.2). 
3.4.3.2 Ligation of DNA fragments 
For ligations 1 µl T4 ligase was used per 30 µl 1 x T4 buffer. About 2 µg of total DNA were used and 
the molar ratio of the vector and the insert was chosen to be 1:3. The mixture was incubated overnight 
at RT. The DNA was stored at 4 °C until being transformed into E. coli (3.4.1.3). 
3.4.3.3 PCR 
For the amplification of DNA fragments a polymerase chain reaction (PCR) according to Saiki et al., 
1988 was performed. 50 ng plasmid DNA was mixed with 3 µM primer (fwd and rev), 160 µM dNTPs 
(each) and 2.5 U PfuTurbo DNA polymerase in 50 µl 1 x Pfu DNA polymerase reaction buffer. The 
DNA was amplified in a thermocycler using the following PCR conditions: 95 °C for 2 min, followed by 
30 cycles 95 °C / 30 s, 55 °C / 30 s and 72 °C / 30 s. After 7 min at 72 °C the PCR product was stored 
at 4 °C before being purified with the QIAquick Gel Extraction Kit using the QIAquick PCR Purification 
Kit protocol. 
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3.4.3.4 Colony PCR 
The colony PCR was used to screen for successful ligations. For each reaction a mixture consisting of 
1 µl GOTaq polymerase, 0.4 µM primers (fwd and rev) and 0.6 mM dNTPs in a total volume of 50 µl in 
1 x PCR buffer was prepared. A small amount of an E. coli colony from an agar plate was transferred 
into the mixture with a yellow pipet tip and mixed. As controls the according plasmid with and without 
insert were included. 1 µl of this PCR mixture was transferred into 100 µl antibiotic containing LB to 
cultivate the bacterial clone at 37 °C under gentle agitation. 
To amplify the DNA fragment the following PCR conditions were used: 95 °C for 5 min, followed by 
35 cycles 95 °C / 60 s, 54 °C / 90 s and 72 °C / 60 s. After 5 min at 72 °C the PCR was stored at RT 
until being analysed on an agarose gel (3.4.2.2). Positive clones were selected and 1.9 ml LB medium 
containing the appropriate antibiotic was added to the bacteria culture for further growth. 
3.4.3.5 Sequencing of DNA 
DNA was sequenced using the sequency facility of the University Hospital Münster. For that purpose, 
the purified DNA was amplified via PCR using the BigDye Terminator Cycle Sequencing Kit. 
300 ng plasmid DNA was incubated with 1 µl BigDye and 0.5 µM primer in 1 x BigDye buffer in a total 
volume of 10 µl in a thermocycler. The following PCR conditions were used: 96 °C for 5 min, followed 
by 25 cycles at 96 °C / 10 sec and 55 °C / 4 min. The reaction volume was adjusted to 20 µl and the 
DNA was stored at 4 °C until being sequenced. 
3.4.3.6 Real-time PCR 
The quantitative real-time PCR analysis was used to determine the mRNA level of annexin A1 and 
annexin A2 in PR8-infected A549, HeLa or HepG2 cells. The cells were infected in a 6 cm cell culture 
dish (3.5.1) and the mRNA was isolated at the indicated time points using the RNeasy Mini Kit. The 
mRNA was quantified using the Eppendorf BioPhotometer and 1 µg was transcribed into cDNA with 
the help of the High-Capacity cDNA Reverse Transcription Kit according to the manufacturer’s 
protocol. 
The cDNA preparations were then subjected to real-time PCR using an ABI Prism 7900 HT system. 
The reactions contained Platinum SYBR Green qPCR SuperMix UDG with ROX reference dye and 
appropriate primers (550 nM or 1 x QuantiTect Primer Assay). About 0.2 ng cDNA per 50 µl reaction 
mix were used. 
The following PCR conditions were used: 50 °C for 2 min, then 95 °C for 2 min, followed by 40 cycles 
at 95 °C / 15 sec and 60 °C / 60 sec. All real-time PCR reactions were carried out in duplicate. The 
expression level of the gene of interest was normalised to GAPDH controls using the 2-ΔΔC(T)-method 
(Livak and Schmittgen, 2001). 
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3.4.4 Cloning of mCherry labelled annexin A2 constructs  
The GFP-tag of anxA2-GFP wt and mutants was substituted with mCherry to obtain red labelled 
annexin A2 constructs that could be used for Laurdan microscopy (3.2.7). 
mCherry was amplified from pRSET-B mCherry using mCherry primers harbouring BamH I and Not I 
cutting sites (3.4.3.3). The purified PCR product as well as the plasmid anxA2-GFP were digested with 
BamH I and Not I for 2 h at 37 °C (3.4.3.1). After heat inactivation of the enzymes the DNAs were 
separated on an agarose gel. The desired vector backbone as well as the mCherry insert were 
isolated from the gel (3.4.2.3) and ligated (3.4.3.2). The ligation mixture was transformed into E. coli 
which were selected with kanamycin (3.4.1.3). For identification of successful ligations a colony PCR 
was performed using mCherry primers (3.4.3.4). Positive clones were amplified in a small scale and 
sequenced with pEGFP-N.3’.2-primer (3.4.3.5). The correct expression of mCherry tagged annexin A2 
was verified by transfecting the construct into A549 cells (3.2.4.1) and analysing the red fluorescence 
by confocal microscopy. The mCherry insert of one positive clone was cut out with BamH I and Not I 
and ligated with the purified vector backbone of either anxA2 YE-GFP, YF-GFP, KA-GFP, PM-GFP, 
PMCM-GFP or GFP that was cut with the same enzymes. Recombinant plasmids were identified by 
transformation of competent E. coli and selection with kanamycin, followed by colony PCR. The 
correct insertion of mCherry was verified by sequencing using pEGFP-N.3’.2-primer. Positive clones 
were amplified in large scale. 
3.5 Virological methods 
All experiments involving influenza A viruses were performed at the Institute of Medical Virology, 
University of Münster. 
3.5.1 Viral infection of cells 
Cells were washed with PBS before being incubated with an appropriate dilution of virus in infection 
PBS. The incubation was performed for 30 min at 37 °C and 5 % CO2. Afterwards the virus was 
removed and the cells were washed before further cultivation in infection medium. To determine the 
amount of infectious virus particles in the supernatants of the infected cells a plaque assay was 
performed (3.5.2) and the infections were carried out in duplicate. Where indicated cell lysates of the 
infected cells were made (3.3.1) or the cells were prepared for real-time PCR analysis (3.4.3.6). 
 
infection PBS 
Dulbecco’s PBS 
1 mM MgCl2 
0.9 mM CaCl2  
100 units/ml penicillin 
0.1 mg/ml streptomycin  
0.2 % (w/v) BA 
infection medium 
DMEM or MEM 
1 mM MgCl2 
0.9 mM CaCl2  
100 units/ml penicillin 
0.1 mg/ml streptomycin  
0.2 % (w/v) BA 
[0.000 06 (v/v) % trypsin SOLO for PR8] 
3.5.2 Plaque assay 
To determine the amount of infectious virus particles in the supernatant of infected cells or to 
determine the virus titre of propagated viruses standard plaque assay on MDCK according to Gaush 
and Smith, 1968 was performed. 
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One 6-well plate of MDCK-IMV grown to confluency was used for each virus solution. The cells were 
infected with 500 µl of a logarithmic dilution of the virus as described above (3.5.1). After the infection 
the virus was removed and the cells were covered with 2 ml agar medium. This agar medium 
consisted of a fresh mixture of 15 ml 46 °C warm 3 % agar and 35 ml 37 °C warm 2 x MEM. After 
hardening of the agar medium the 6-well plates were incubated upside down in a CO2 incubator until 
analysis of the plaques (2 d for FPV, 3 d for PR8). The plaques were visualised by staining the agar 
with a dilution of neutral red in PBS for 1 h at 37 °C. The plaques were counted and the amount of 
plaque forming units (PFU) per ml was calculated. 
 
2 x MEM 
14.3 % (v/v) 10 x MEM 
143 units/ ml penicillin 
0.143 mg/ml streptomycin 
0.268 % NaHCO3 (from 7.5 % (w/v) stock) 
0.014 % (w/v) DEAE-dextran 
0.3 % (w/v) BA 
[0.000 086 % (v/v) Trypsin SOLO 
1.43 mM MgCl2 
1.29 mM CaCl2 for PR8] 
3.5.3 Influenza virus propagation  
3.5.3.1 Propagation of FPV in MDCK 
FPV was propagated on MDCK-IMV by infecting the cells as described above (3.5.1). An MOI of 0.001 
was used for this infection. When the cytopathic effect was visible (after 24 h to 48 h) the supernatant 
was harvested and clarified by low-speed centrifugation (10 min at 2 000 rpm; Eppendorf C5810R). 
The virus titre could be determined by plaque assay (3.5.2) or the virus was purified as described 
below (3.5.4). 
3.5.3.2 Propagation of PR8 in embryonated chicken eggs  
The human influenza virus PR8 efficiently propagates in chicken eggs. 11 - 14 days old chicken 
embryos were used. Inocculation of the eggs and harvesting of the virus were performed as sterile as 
possible. To achieve this, eggs and all materials used were disinfected with 70 % ethanol. 
A small hole was drilled at the bottom side of an egg to inject the virus (1*10-4 - 1*10-5 PFU / 100 µl 
infection PBS) with a sterile syringe into the allantoic fluid. The hole was closed with glue (Ponal) and 
the eggs were incubated for 50 h at 37 °C and 70 % humidity. 
After the chicken embryos were killed by incubating the eggs at -20 °C for 2 h or at 4 °C overnight the 
virus was harvested by gently opening and removing the shell at the bottom of the egg with the help of 
a spoon and tweezers. The virus containing fluid of the allantois was removed. The amount of 
infectious virus particles was determined by plaque assay (3.5.2) and the virus was stored at -80 °C. 
3.5.4 Influenza virus purification 
1.5 ml of FPV propagated on MDCK-IMV cells for 24 h (3.5.3.1) was spun for 2 min at 14 000 rpm at 
4 °C (Eppendorf 5417R) to remove cellular debris. The supernatant was then layered on top of a 
sterile 400 µl sucrose cushion (20 % (w/v) sucrose in water) in a 2 ml test tube. After centrifugation for 
90 min at 14 000 rpm at 4 °C the supernatant was discarded except the last 20 µl which contain the 
purified virus particles. 
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4 Results 
4.1 Role of annexin A2 in IAV infection 
4.1.1 Annexin A2 dependency of IAV replication 
4.1.1.1 IAV replication in XM expressing cells 
Finding novel cellular proteins that are of importance for the infection of IAV could help in defining new 
strategies to fight the causative agent of the flu. To investigate whether annexin A2 is involved in the 
life cycle of IAV the replication of this virus in different cell lines with different annexin A2 protein levels 
was examined. 
First, an MDCK cell line was used that can be induced to express a dominant negative annexin A2/p11 
chimeric protein. This so-called XM protein precipitates endogenous annexin A2 and p11 and thus 
interferes with its function (Harder and Gerke, 1993). The mode of action of this chimeric protein is 
explained in detail in Figure 4-1. 
 
N-terminal domain of anxA2
anxA2 core domain
XM = anxA2/p11 chimera
p11 dimer
anxA2/p11 heterotetramer
expression of
 
 
Figure 4-1: Schematic presentation of multimeric annexin A2/p11 aggregates induced by the anxA2/p11 
chimera 
A chimera comprising the N-terminal region of annexin A2, i.e. the entire p11-binding domain, fused to a complete 
p11 protein is still able to dimerise and bind annexin A2 and also binds additional p11 dimers via its N-terminus. 
Expression of such a trivalent chimera in cells containing the annexin A2/p11 complex therefore leads to the 
formation of large aggregates containing endogenous annexin A2 and p11 in addition to the chimeric protein. 
From Harder and Gerke, 1993. 
 
The MDCK cell line used for these experiments stably expresses the XM protein under the control of a 
tetracycline (tet)-dependent promoter. For the induction of the chimeric protein the cells were 
incubated for four days without the addition of tet. The expression can be checked by 
immunofluorescence analysis. As shown in Figure 4-2 A the expression of the XM protein can be seen 
by the induction of aggregates of annexin A2 and p11. This leads to a depletion of cytosolic 
annexin A2. Membrane bound annexin A2 is influenced to a reduced extent by the expression of the 
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anxA2/p11 chimera. Another possibility to verify the XM expression is western blot analysis (Figure 
4-2 B). The XM protein can be visualised with an anti-p11 antibody. The protein is about 2 kDa larger 
than endogenous p11. 
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Figure 4-2: Immunofluorescence and western blot analysis of XM expression in MDCK 
MDCK-XM cells were either cultivated as control in the presence of tet (XM off) or were induced to express the 
chimeric protein (XM on) by the removal of tet for four days. A) The expression of XM was verified by 
immunofluorescence analysis. Cells were fixed and permeabilised and annexin A2 was visualised with the 
antibody H28 and p11 with H21. As secondary antibody GMs Cy2 was used. Precipitates of annexin A2 and p11 
can be detected after the expression of XM (arrows; scale bars: 10 µm). B) The induction of the XM protein can 
be visualised in a western blot of cell extracts. An p11 antibody (H21) reveals a band running slightly slower than 
p11 in XM expressing cells in addition to the endogenous p11 protein. 
 
In initial experiments performed before this thesis the human influenza strain influenza A/Puerto-
Rico/8/34 (PR8) appeared to replicate with about 50 % reduced efficiency in XM expressing cells in 
comparison to control cells (unpublished observation by Torben Hausrat). This influence of the XM 
protein could only be seen after a replication period of 8 h but not after 24 h any more and also not 
when the experiment was repeated. No alteration of the replication of the avian influenza virus 
A/Bratislava/79 (FPV) upon XM expression could be detected. For this reason and because it was 
thought to better reflect a relevant situation for humans PR8 was used for the infection experiments. 
The expression of the XM protein was induced in MDCK-XM and four days afterwards the cells were 
infected with PR8. Prior to infection the cells were examined with a phase contrast microscope to 
verify that the cell number was not altered by the induction of the XM protein. The number of infectious 
virus particles in the supernatant of the cells was determined via plaque assay after the indicated time 
periods of infection. Different infection times were chosen varying from 8 h (about one replication 
cycle) to 24 h (about three replication cycles). Cell lysates were made of the infected cells to verify the 
expression of the XM protein via western blot analysis (one example can be seen in Figure 4-2 B). As 
control MDCK-XM cells that were not induced to express the chimeric protein were infected using the 
same conditions. 
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Figure 4-3: The expression of the XM protein does not have an obvious influence on the replication 
efficiency of PR8 
MDCK-XM cells were induced to express the XM protein for four days. The cells were infected with PR8 for 
30 min with different MOIs followed by different replication times. In parallel MDCK-XM cells not expressing the 
XM protein were infected as a control using the same conditions. The number of infectious virus particles in the 
supernatant of infected XM expressing cells and control cells not expressing the chimeric protein was determined 
via plaque assay. The virus titre in the supernatant of infected XM expressing MDCKs is presented as % of the 
supernatant of wt MDCK-XM infected under the same conditions. Three independent experiments were 
performed each using different MOIs and replication times which were partly overlapping and are indicated at the 
x-axis. The means are indicated by horizontal lines. The results of the individual experiments are presented in the 
appendix. 
 
In MDCK cells expressing the XM protein endogenous annexin A2 and p11 form aggregates and 
cannot function any more in this state. This depletion of annexin A2 does not result in a detectable 
tendency to an altered replication efficiency of the human IAV PR8 (Figure 4-3). The observed 
differences were in the range of variances of viral infection assays and were not significant. Thus, the 
influenza replication in XM expressing cells seems to be as effective as in wt MDCKs not expressing 
this protein. 
4.1.1.2 IAV replication in annexin A2 siRNA transfected cells 
As a further approach to investigate a potential role of annexin A2 in influenza infection HeLa were 
depleted for endogenous annexin A2 by means of siRNA and infected with the human IAV strain PR8. 
HeLa cells are a human epithelial cell line derived from a cervical carcinoma that are easy to transfect 
and established. siRNA mediated down-regulation of annexin A2 in these cells leads to a decrease of 
the protein level to about 30 - 50 %. The reduction of the annexin A2 protein level was verified for 
each experiment via western blot analysis (Figure 4-4). 
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Figure 4-4: Annexin A2 depletion by siRNA in HeLa cells  
HeLa were transfected with annexin A2 siRNA (A2) or non-targeting control siRNA (co). Two days after 
transfection total cellular lysates were subjected to SDS-PAGE and immunoblotted for annexin A2 (HH7) or 
vimentin as a loading control. Densitometric analysis revealed a reduction of the cellular annexin A2 level to 
30 to 50 %. 
 
However, IAV replication is described to be defective in HeLa cells. These cells have been reported to 
show defects in the maturation and membrane insertion of HA, in the M1 production and in the 
budding process (Gujuluva et al., 1994; Lohmeyer et al., 1979; Portincasa et al., 1990). Nevertheless, 
the HeLa cells used here were permissive to the IAV strain PR8. The achieved viral titres were in the 
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range of 105 - 106 PFU/ml and therewith hardly differ from those obtained in e.g. MDCK cells. IAV has 
been shown before to efficiently replicate in HeLa cells (Yang et al., 2009). Discrepancies to the above 
mentioned observations could possibly arise from the heterogeneities in specific cell clones in the 
various laboratories. Because HeLa cells are a well established model cell line and could be readily 
infected with IAV they were used for infection experiments, even though their use for influenza virus 
infection has been criticised. 
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Figure 4-5: siRNA mediated down-regulation of cellular annexin A2 does not lead to a detectable 
difference in the replication efficiency of PR8 in HeLa cells  
HeLa were transfected with annexin A2 siRNA or non-targeting control siRNA. Two days after transfection those 
cells as well as untransfected HeLa were infected with PR8. After different infection times the number of infectious 
virus particles in the supernatant of the cells was determined with a plaque assay. The virus titre in the 
supernatant of infected siRNA transfected cells is presented as % of the supernatant of untransfected cells 
infected under the same conditions (annexin A2 siRNA in black, control siRNA in grey). Five independent 
experiments were performed each using different MOIs and replication times which were partly overlapping and 
are indicated at the x-axis. The means are indicated by horizontal lines. The results of the individual experiments 
are presented in the appendix. 
 
For the infection of siRNA transfected HeLa cells different experimental conditions were used as 
explained in the caption of Figure 4-5. Prior to infection the cells were examined with a phase contrast 
microscope to verify that the cell number was not altered by siRNA transfection. Infectious virus titres 
in the supernatant of infected siRNA transfected HeLa cells sometimes differ from those of 
untransfected cells but the differences were in the range of variances of plaque assays and were not 
significant. No tendency to an either reduced or an enhanced replication upon annexin A2 depletion 
could be detected. Hence, the transfection of annexin A2 siRNA as well as control siRNA in HeLa 
does not have a detectable influence on the replication efficiency of PR8 as can be concluded from 
the results of the plaque assay. 
 
An analogous experiment was performed using the lung epithelial cell line A549 which is a well 
suitable model cell line for influenza infections since the lung is the location of the primary infection of 
this virus. Transfection of these cells with annexin A2 siRNA leads to an about 60 to 70 % reduction of 
the protein level which was verified for each experiment via western blot analysis (Figure 4-6). 
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Figure 4-6: Annexin A2 depletion by siRNA in A549 cells 
A549 were transfected with annexin A2 siRNA (A2) or non-targeting control siRNA (co). Two days after 
transfection total cellular lysates were subjected to SDS-PAGE and immunoblotted for annexin A2 (HH7) or 
vimentin as a loading control. Densitometric analysis revealed a reduction of the cellular annexin A2 level to about 
30 to 40 %. 
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Figure 4-7: siRNA mediated down-regulation of cellular annexin A2 does not lead to a detectable 
difference in the replication efficiency of PR8 in A549 
A549 were transfected with annexin A2 or non-targeting control siRNA. Two days after transfection those cells 
were infected with PR8. After different viral replication times the number of infectious virus particles in the 
supernatant of the cells was determined via plaque assay. The virus titres in the supernatants of infected 
annexin A2 siRNA transfected cells is presented as % of the supernatants of control siRNA transfected cells 
infected using the same conditions. Three independent experiments were performed each using different MOIs 
and replication times which were partly overlapping and are indicated at the x-axis. The means are indicated by 
horizontal lines. The results of the individual experiments are presented in the appendix. 
 
A549 cells transfected with annexin A2 or control siRNA were infected with the human IAV strain PR8. 
The number of infectious virus particles in the supernatant of annexin A2 siRNA transfected A549 cells 
compared to control siRNA transfected A549 cells was determined via plaque assay but no tendency 
to an altered virus replication could be detected ( 
Figure 4-7). 
Untransfected cells were not included in the data analysis because virus titres in the supernatant of 
these cells were much higher than in the supernatant of siRNA transfected cells. This remarkably 
elevated virus propagation was probably due to an enhanced viability of untransfected cells since the 
transfection procedure with Lipofectamine 2000 stressed the A549 cells to a visible extent. 
4.1.1.3 IAV replication in CMECs from an annexin A2 knockout mouse 
In the above mentioned approaches to investigate the influence of annexin A2 on IAV propagation 
only an incomplete down-regulation of the annexin A2 protein level could be achieved. Cytosolic 
annexin A2 levels are reduced sufficiently by transient siRNA transfection or XM expression. However, 
membrane bound annexin A2 remains rather unaffected (Zobiack et al., 2003). Thus, a role of 
membrane associated annexin A2 in IAV replication cannot be ruled out. Since the achieved 
reductions of the annexin A2 protein level are only partly and not absolute it might furthermore be 
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possible that a certain threshold level of the protein is still present in the siRNA transfected cells that is 
sufficient for efficient IAV replication. 
 
Therefore, as another possibility to investigate a potential role of annexin A2 in IAV infection a cell line 
from the annexin A2 knockout mouse from the group of Katherine A. Hajjar was used in another line of 
experiments. Cardiac microvascular endothelial cells (CMECs) isolated from a wt mouse or an anxA2-/- 
mouse were available for this analysis (Ling et al., 2004). 
FPV in CMEC
1 MOI 8 h 0.1 MOI 16 h 0.1 MOI 24 h 
0
50
100
150
PR8 in CMEC
3 M
OI
 8 
h
MO
I 1
6 h
MO
I 2
4 h
0
50
100
150
%
 o
f C
M
EC
 A
2 
-/-
 c
om
pa
re
d 
to
 A
2 
+/
+
vi
ru
s
tit
re
in
 C
M
EC
 A
2
-/-
co
m
pa
re
d
to
 C
M
EC
 A
2+
/+
 (%
) 
0.1 MOI
16 h
0.1 MOI
24 h
0.1 MOI
24 h
0.1 MOI
16 h
1 MOI
8 h
0.3 MOI
8 h
A) B)
 
Figure 4-8: IAV replication in CMECs of an anxA2-/- mouse seems to be as effective as in CMECs of an 
anxA2+/+ mouse  
CMECs of the anxA2-/- mouse as well as CMECs of an anxA2+/+ mouse were infected either with A) the human 
IAV PR8 or B) the avian IAV FPV. At different time points p.i. the supernatant was harvested and the amount of 
infectious virus particles was determined via plaque assay. The virus titre in the supernatant of infected CMECs of 
the anxA2-/- mouse is presented as % of the titre in the supernatant of CMECs of the anxA2+/+ mouse that were 
infected using the same experimental conditions. Three independent experiments were performed each using 
different MOIs and replication times which were partly overlapping and are indicated at the x-axis. The means are 
indicated by horizontal lines. The results of the individual experiments are presented in the appendix. 
 
The cells were infected for different time points with different MOIs (Figure 4-8). For these experiments 
not only the human IAV strain PR8 but also the avian influenza virus A/Bratislava/79 (FPV) was used 
to also analyse a different IAV strain for its dependency on annexin A2. The viral titres that could be 
achieved in this epithelial cell line ranged between 104 - 105 PFU/ml for PR8 and 105 - 107 PFU/ml for 
FPV. Hence, this cell line could be readily infected by IAV. However, the number of infectious virus 
particles in the supernatant of infected CMECs of the anxA2-/- mouse does not show a detectable 
tendency to differ from that in the supernatant of CMECs of an anxA2+/+ mouse. 
4.1.2 Real-time PCR analysis of annexin A1 and annexin A2 after IAV infection 
Viral infections usually result in alterations in the host cell proteome which determine the fate of the 
infected cells and the progress of pathogenesis. Also the IAV is known to influence the transcription of 
a range of proteins. 
To determine whether IAV infection has an influence on the mRNA level of annexin A2 quantitative 
real-time PCR analysis of PR8 infected cells was performed. Not only was the regulation of 
annexin A2 mRNA determined but also the regulation of annexin A1 mRNA. Annexin A1 is another 
well characterised member of the annexin protein family. It has anti-inflammatory activities (Perretti 
and Gavins, 2003). Furthermore, annexin A1 is a major substrate of the EGF receptor tyrosine kinase 
and has been implicated in the endocytic transport of this receptor. The phosphorylation by the EGF 
Results 39
receptor kinase can probably be linked to an anti-proliferative activity on annexin A1. For a review on 
annexin A1, see Lim and Pervaiz, 2007. Because IAV interacts with the cellular innate immune 
signalling (Ehrhardt et al., 2009) and cellular proliferation is also of importance for influenza virus 
propagation annexin A1 might be of importance for influenza replication. 
The cell lines HeLa and A549 were used for this real-time PCR analysis. Those cell lines were used 
for IAV infection experiments before. Furthermore, PR8 infected HepG2 cells were analysed. This cell 
line expresses no or very little endogenous annexin A2 and p11 protein but it still possess the mRNA 
coding for p11 (Puisieux et al., 1996). The statements in the literature concerning the annexin A2 
mRNA are contradictory. Puisieux and Ozturk were not able to detect annexin A2 mRNA in HepG2 
(Puisieux et al., 1996). In contrast, Mayer and colleagues did identify annexin A2 mRNA in this cell line 
by real-time PCR analysis (Mayer et al., 2008). However, how this mRNA is regulated is not clear. The 
HepG2 clone used in this thesis also possesses annexin A2 mRNA but the protein could not be 
detected by western blot analysis (data not shown). 
 
Table 4-1: Quantitative real-time PCR analysis does not reveal a difference in annexin A1 or annexin A2 
mRNA level after IAV infection 
A549, HeLa or HepG2 were infected with 5 MOI PR8 for 2.5 h, 5.5 h, 8 h or 16 h. The mRNA of the cells was 
isolated and the levels of annexin A1, annexin A2, M1 and GAPDH mRNAs were determined via real-time PCR 
analysis. Presented in the table are the calculated “n-fold induction” of different time points of three independent 
experiments. (n.d.: not determined) 
 
mRNA cell line infection time experiment 1 experiment 2 experiment 3 
      
annexin A2 A549 2.5 h 1.1 -1.0 1.0 
  5.5 h n.d. -1.2 -2.5 
  8 h -1.4 1.5 -1.1 
  16 h n.d. -4.1 -1.1 
      
 HeLa 2.5 h n.d. -1.1 1.1 
  5.5 h n.d. 1.4 2.6 
  8 h n.d. -1.3 -1.2 
  16 h n.d. 2.3 -1.3 
      
 HepG2 2.5 h n.d. -1.9 1.1 
  5.5 h n.d.  1.0 
  8 h n.d. -3.2 -1.3 
  16 h n.d.  -1.2 
      
annexin A1 A549 2.5 h 1.1 -1.1 1.1 
  5.5 h n.d. 2.4 -5.3 
  8 h -1.1 2.0 1.0 
  16 h n.d. -33.7 1.0 
      
 HeLa 2.5 h n.d. -1.3 1.2 
  5.5 h n.d. -1.4 6.8 
  8 h n.d. -1.3 1.1 
  16 h n.d. 18.2 -1.2 
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M1 is a viral structural protein highly expressed in IAV infected cells. M1 mRNA was detected to verify 
that the infection of the cells and the transcription of viral genes occurred. A remarkable up-regulation 
of M1 mRNA could be detected after 2.5 h and 5.5 h (data not shown). 
In the HepG2 cell line not every time point could be analysed because the corresponding C(T) values 
of GAPDH could not be determined. Furthermore, the level of annexin A1 mRNA in this cell line was 
below the detection limit of the real-time PCR. Therefore, HepG2 could not be analysed for the 
expression of this protein. An alteration of the annexin A1 or annexin A2 mRNA after PR8 infection 
could not be measured in any of the cell lines used under the experimental conditions chosen here. 
4.1.3 Hemagglutinin localisation in annexin A2 depleted cells 
Annexin A2 is involved in the apical transport of raft associated proteins in polarised cells (Jacob et al., 
2004). Influenza HA is a raft associated protein and this association is of importance for an efficient 
viral replication (Takeda et al., 2003). Therefore, the question arose whether annexin A2 is involved in 
the transport of influenza HA. A549 cells that were depleted for annexin A2 by means of siRNA were 
used for these experiments. These cells were transfected with a plasmid encoding the HA protein of 
influenza A/FPV/Rostock/34 (H7-HA) (Marjuki et al., 2006). The surface localisation of H7-HA was first 
analysed by immunofluorescence ( 
Figure 4-9). 
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Figure 4-9: Annexin A2 depletion of A549 does not alter the surface localisation of influenza HA as 
determined by confocal immunofluorescence analysis 
A549 seeded on coverslips were transfected with annexin A2 or control siRNA. 48 h after siRNA transfection the 
cells were transfected with a plasmid encoding H7-HA. The next day surface localisation of hemagglutinin was 
determined after fixation of the cells and incubation with a polyclonal H7-HA antibody and Cy2 labelled GMs 
antibody. Cells were not permeabilised to ensure that only surface HA is visualised. Representative pictures of 
four independent experiments are depicted here. (scale bars: 5 µm) 
 
The plasmid encoded HA of FPV/Rostock localises to the surface of A549 cells as determined by 
confocal immunofluorescence microscopy. This localisation is not altered upon depletion of cytosolic 
annexin A2 by siRNA. 
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The surface expression of HA was quantified via flow cytometric analysis. A549 cells transiently 
expressing H7-HA were labelled with specific antibodies and analysed by FACS measurements. Cells 
that were transfected with annexin A2 or control siRNA prior to plasmid transfection were included in 
these experiments to be able to assess the role of annexin A2 in the surface transport of influenza HA 
in A549. 
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Figure 4-10: Flow cytometric analysis of HA surface expression in A549 does not reveal a dependency of 
HA transport on cytosolic annexin A2 
A549 were depleted for annexin A2 by transfection with annexin A2 siRNA. 48 h later the cells were transfected 
with a plasmid encoding H7-HA. 72 h after siRNA transfection the surface localisation of HA was determined via 
flow cytometry using the monoclonal H7-HA antibody and a FITC labelled GRb antibody. As controls 
untransfected cells as well as cells transfected with H7-HA but not depleted for annexin A2 (either no siRNA or 
control siRNA) were stained and analysed. Gates were set to quantify the fluorescence. Here representative 
histograms of the HA fluorescence of three independent experiments are depicted.  
 
Surface expression of HA could be detected by a shift of the fluorescence in the flow cytometer. About 
15 to 25 % of the total fluorescence was shifted to the right when H7-HA was expressed. This amount 
was not altered significantly when cells were transfected with control or annexin A2 siRNA. 
These data as well as the immunofluorescence data indicate that the A549 cells used for these 
experiments do not require cytosolic annexin A2 for the transport of influenza HA to the cell surface. 
4.1.4 Annexin A2 and FPV localisation in infected cells 
To further determine a possible involvement of annexin A2 in IAV infection the localisation of this 
protein as well as the localisation of the virus in FPV infected A549 cells was analysed via confocal 
immunofluorescence microscopy. The avian influenza FPV was used for this study because an 
antibody was available to visualise this virus. This was not the case for PR8. Different time points were 
chosen for this analysis varying from 0 h to determine the background staining of the antibody to 8 h at 
the end of the viral replication cycle (Figure 4-11). 
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Figure 4-11: Annexin A2 and IAV do not colocalise in A549 cells 
A549 seeded on coverslips were infected with 30 MOI FPV for 0 h, 30 min, 1 h, 2 h or 8 h, fixed, permeabilised 
and stained with H7-HA in combination with GRb Alexa488 as a secondary antibody. Annexin A2 was 
visualised using HH7 and GMs TxRed. Representative pictures of three independent experiments are depicted 
here. (scale bars: 10 µm) 
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In IAV infected cells annexin A2 shows a typical cytoplasmatic distribution. It is excluded from the 
nucleus and sometimes localised to the cellular membrane. At early infection points a patchy 
distribution of the virus on or near the cellular surface could be detected. After 30 min infection the 
anti-FPV antibody decorates structures localised near the cellular membrane. After 1 h and 2 h these 
punctual structures are distributed more throughout the cytosol. Following 8 h infection viral protein 
could mostly be detected close to the cellular membrane, indicating that new virus particles assemble 
at these sites and the replication cycle is almost completed. 
At none of these infection time points a redistribution of annexin A2 or a colocalisation of this protein 
with FPV-positive structures was detectable. 
4.1.5 Annexin A2 incorporation in IAV particles 
Enveloped virions released from infected cells carry numerous proteins from the host cell. Some of the 
identified host cell proteins may play an important role in viral replication (Cantin et al., 2005). Also 
annexin A2 and other annexins have been shown to be incorporated into viral particles of e.g. HIV-1, 
herpes simplex virus 1, vesicular stomatitis virus and HCMV (Harrist et al., 2009; Moerdyk-
Schauwecker et al., 2009; Padula et al., 2009; Wright et al., 1995). 
To investigate whether annexin A2 was incorporated into influenza virions purified virus particles were 
analysed via western blot for annexin A2 (Figure 4-12). For this study the avian virus FPV was used 
because it can easily be propagated on MDCKs and much higher virus concentrations can be 
achieved with this strain in comparison to the human strain PR8. 
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Figure 4-12: Annexin A2 is incorporated into influenza A virions 
FPV was propagated on MDCK cells and purified by centrifugation through a 20 % sucrose cushion. The pelleted 
virus particles were resuspended in sample buffer, separated on an SDS-PAG and analysed via western blotting. 
M1 and NS1 were detected with the help of specific antibodies. Annexin A2 was visualised using HH7. The left 
lane shows cell lysates of MDCKs infected with FPV, the right lane shows lysates of the purified virions. 
Presented here is the only experiment that did not show a contamination with NS1. 
 
Western blot analysis revealed the presence of annexin A2 in purified FPV particles in addition to the 
viral matrix protein M1. In contrast, the non-structural protein NS1 was not detected in the virions. This 
influenza protein is synthesised in the host cell during the course of infection but it is not a structural 
protein of the virus particle. The absence of NS1 in the FPV preparation indicates that the virus lysate 
contains no or only very little contamination with cellular debris. 
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4.2 Involvement of annexin A2 in apoptotic processes 
Influenza viruses induce apoptosis in infected cells. On the one hand this is a host mechanism to limit 
virus spread but on the other hand IAV has taken advantage of some of the apoptotic processes to 
efficiently replicate. E.g. it has been demonstrated that the activation of caspase-3 is important for 
efficient IAV replication (Wurzer et al., 2003). 
In the experiments performed here IAV infected cells showed morphological changes reflecting those 
of apoptosis: the cell body rounds up and looses the contact to the substratum. It was noted that 
annexin A2 depleted cells showed more drastic morphological changes upon IAV infection than 
control siRNA transfected cells. To verify whether this visual observation is indeed due to increased 
apoptosis the cleavage of PARP (poly(ADP-ribose) polymerase) was detected. PARP is a direct 
substrate of the effector caspase-3. The cleavage of PARP as detected by western blot analysis is 
therefore an indicator for the onset of apoptosis. 
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Figure 4-13: PARP cleavage after IAV infection is increased in annexin A2 depleted cells 
HeLa cells transfected with the indicated siRNAs were infected with 5 MOI PR8 for 8 h and cell lysates were 
made. The lysates of the infected cells were separated on an SDS-PAG, transferred onto a PVDF membrane and 
cleaved PARP was detected by means of a specific antibody. Annexin A2 depletion was confirmed by detection of 
the protein level with the antibody HH7. The experiment was performed in duplicate because the amount of 
infectious virus particles in the supernatants of the cells was analysed by plaque assay (see Figure 4-5). A 
representative blot of three independent experiments, each employing several infection conditions, is depicted 
here. 
 
HeLa cells that were depleted for annexin A2 by means of siRNA were infected with PR8. The virus 
titres in the supernatants of the cells were determined by plaque assay as described above (see 
Figure 4-5). Lysates of the cells were analysed by western blot for the cleavage of PARP and for 
annexin A2 depletion. Cells that were depleted for annexin A2 show a remarkable increase in the 
cleavage of PARP ( 
Figure 4-13). This phenomenon could also be seen with other virus titres and infection times and also 
in A549 cells (data not shown). This indicates that the visual observation that annexin A2 depleted IAV 
infected cells show more drastic apoptotic like morphological changes than control cells indeed 
reflects a different onset of apoptosis. 
 
When infecting CMECs with influenza the cells from the annexin A2 knockout mouse showed 
increased morphological changes when compared to wt CMECs. This visual observation was similar 
to that of PR8 infected HeLa cells. Therefore, also cell lysates of virus infected CMECs were made 
and analysed for PARP cleavage (Figure 4-14). CMECs of the anxA2-/- mouse show an increase of the 
PARP cleavage after IAV infection when compared to wt CMECs. This effect could only be seen after 
prolonged infection times though. 
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Figure 4-14: PARP cleavage is enhanced in IAV infected CMECs of the anxA2-/- mouse than in CMECs of a 
wt mouse 
CMECs were infected with IAV as described in the caption of Figure 4-8. The lysates of the infected cells were 
used to detect the PARP cleavage by western blot analysis. Furthermore, annexin A2 was detected with the help 
of the specific antibody from BD Transduction Lab to demonstrate the cellular level of this protein. The viral titres 
used in this experiment were for PR8 0.3 MOI for 8 h and 0.1 MOI for 24 h and for FPV 1 MOI for 8 h and 0.1 MOI 
for 24 h. A representative blot of three different experiments is shown here. 
 
The mechanisms being involved in influenza-induced apoptosis are very complex and only partly 
understood. To better understand the involvement of annexin A2 in apoptotic processes the influence 
of annexin A2 depletion on the effects of other apoptotic stimuli was investigated. 
Staurosporine is commonly used as an initiator of apoptosis (Bertrand et al., 1994). The exact 
mechanism of action of this broad-specificity kinase inhibitor remains poorly understood. It has been 
shown in melanoma cells that staurosporine activates Bax and the mitochondrial caspase-dependent 
apoptotic pathway but it also induces apoptosis by caspase-independent pathways (Zhang et al., 
2004). 
In addition, TNF was used as an activator of the receptor mediated apoptotic pathway. TNF-induced 
cytotoxicity is potentiated by inhibitors of protein synthesis like cycloheximide (CHX) (Polunovsky et 
al., 1994). 
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Figure 4-15: Annexin A2 depletion increases apoptosis induction by staurosporine and TNF which can 
be seen through a phase contrast microscope 
Two days after transfecting HeLa cells with the indicated siRNAs the cells were stimulated either with 0.1 µM 
staurosporine (STS) or with 0.1 ng/ml TNF + 10 µg/ml CHX for 5 h. Pictures were taken using an Axiovert 40 C 
brightfield microscope with a 10 x objective using an EOS 350D camera. This effect could be seen in four 
independent experiments using different incubation times. 
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HeLa cells were incubated with either staurosporine or TNF in combination with CHX. Already after a 
short time the apoptosis induction was visible. Annexin A2 depleted cells showed more drastic 
morphological changes than control cells. They appeared more rounded up and detached. This 
observation was similar to the morphological changes of annexin A2 depleted cells upon IAV infection. 
Pictures of cells treated for 5 h with staurosporine or TNF + CHX are depicted here to demonstrate 
this visual observation (Figure 4-15). 
 
Cell lysates were made at different time points after apoptosis induction to check for the cleavage of 
PARP as an indicator for the onset of apoptosis (Figure 4-16). The PARP cleavage was more drastic 
in annexin A2 depleted cells. This effect was independent of the apoptotic stimuli. Even without the 
induction of apoptosis an enhanced PARP cleavage could be seen in some cases. This PARP 
cleavage is probably due to the stress induced by the transfection procedure. 
 
A2 co
STS
Ø A2 co Ø A2 co ØA2 co ØA2 co ØA2 co Ø
0 h 30 min 3 h 0 h 30 min 3 h TNF + CHX
anxA2
cPARP  
 
Figure 4-16: Annexin A2 depletion enhances staurosporine and TNF induced PARP cleavage 
HeLa cells were transfected with the indicated siRNAs (A2: annexin A2, co: control) or not transfected (Ø) and 
were stimulated with 0.1 µM STS or 0.1 ng/ml TNF + 10 µg/ml CHX. After 0 h, 30 min or 3 h cell lysates were 
made and analysed by means of western blot. Cleaved PARP was detected with a specific antibody and 
annexin A2 depletion was verified with the HH7 antibody. A representative blot of four independent experiments is 
shown here. 
 
The decrease of cellular annexin A2 leads to an increased sensitivity of cells to apoptotic stimuli not 
only in HeLa cells but also in A549 cells (data not shown). Overall the signal of the cleaved PARP in a 
western blot is about three times more intense in annexin A2 depleted cells in comparison to control 
cells as could be determined by densitometric measurements. 
 
The cleavage of PARP is a measure of the activity of the effector caspase-3. Caspase-3 on the other 
hand can be activated by the upstream initiator caspases-8 and -9. To investigate to which extent the 
activation of these caspases is also influenced by annexin A2 depletion, HeLa cells were transfected 
with annexin A2 siRNA or control siRNA and stimulated with staurosporine or TNF + CHX for 
different time durations. Cell lysates were made and analysed for the cleaved products of these 
caspases via western blot (Figure 4-17). Not only the PARP cleavage was enhanced in annexin A2 
depleted cells but also the cleavage of the analysed caspase-8 and caspase-9. 
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Figure 4-17: Annexin A2 depletion enhances staurosporine- and TNF-induced caspase-8 and caspase-9 
cleavage 
HeLa cells transfected with the indicated siRNAs (A2: annexin A2, co: control) were stimulated with 0.1 µM STS 
or 0.1 ng/ml TNF + 10 µg/ml CHX. After 0 h, 2 h, 4 h or 6 h cell lysates were made and analysed by means of 
western blot. The cleavage of PARP as well as the cleavage of caspase-8 and caspase-9 was detected with 
specific antibodies and annexin A2 depletion was verified with the antibody from BD Transduction Lab. A 
representative blot of three independent experiments is depicted here. 
4.3 Association of annexin A2 with membrane microdomains 
Membrane rafts have been identified to be the sites of influenza virus budding. Those microdomains 
provide a mean for cellular membranes to locally concentrate effectors to form platforms that function 
in multiple cellular processes. In the case of influenza virus budding they function by locally 
concentrating the influenza glycoproteins HA and NA which leads to the further recruitment of other 
viral components (Suomalainen, 2002). Annexin A2 is one of the few known structural proteins on the 
cytoplasmic site of membrane rafts and is involved in the aggregation and stabilisation of these 
microdomains. This feature of annexin A2 could affect influenza infectivity (see above) and also 
influence a whole range of other pathogens that employ membrane rafts or raft components to enter 
their host (Rosenberger et al., 2000). To further illuminate the function of annexin A2 as a raft protein it 
was investigated which features of annexin A2 are important for the association of this protein with 
these membrane microdomains. 
4.3.1 Cell fractionation by DRM flotation gradient 
Resistance to extraction by detergents, most prominently Triton X-100, at 4 °C is widely used as a 
criterion for rafts and raft-association of cellular proteins and lipids (Brown and London, 1998). 
Isolation of detergent resistant membranes (DRMs) can be followed by equilibrium density gradient 
centrifugation. The DRMs float because of their detergent resistant association with lipids. Separating 
DRMs from detergent soluble material using gradient centrifugation is usually preferable to pelleting. 
Pelleting of DRMs from detergent extracts might lead to contaminations with other sedimentable 
material, e.g. cytoskeletal components (Celis, 2005). 
To analyse the association of endogenous and ectopically expressed annexin A2 with DRMs MDCK-
anxA2-GFP were extracted with Triton X-100 on ice and submitted to a flotation gradient 
centrifugation. This cell line stably expresses GFP labelled annexin A2 in addition to the endogenous 
protein. 
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Figure 4-18: Detergent incubation and subsequent saccharose density gradient centrifugation results in 
the flotation of endogenous and ectopically expressed annexin A2 to low density fractions 
MDCKs stably expressing GFP-tagged annexin A2 (MDCK-anxA2-GFP) were extracted with 1 % Triton X-100 on 
ice and a saccharose gradient centrifugation was performed. Fractions were collected from the top and the 
proteins were concentrated by TCA precipitation. The proteins were separated on an SDS-PAG and transferred 
onto a PVDF membrane. Caveolin as a marker for detergent resistant membranes and transferrin receptor as a 
marker for detergent soluble fractions were visualised with the help of specific antibodies. For the detection of 
endogenous annexin A2 and ectopic annexin A2-GFP the annexin A2 antibody from BD transduction 
laboratories and the GFP antibody were used, respectively. This blot depicts the only successful gradient 
centrifugation performed in this thesis. 
 
The endogenous annexin A2 of MDCK-anxA2-GFP as well as the ectopically expressed annexin A2-
GFP float to low density fractions in a saccharose gradient as does the raft marker caveolin. The non-
raft marker transferrin receptor can only be detected in high density fractions. 
 
However, fairly often flotation density gradients did not show the expected results. The DRM marker 
caveolin did not float in these cases. And in some cases the non-raft marker transferrin receptor could 
be detected to a remarkable extent in low density fractions. This is probably due to the fact that this 
method shows an inherent variability in terms of results (Lingwood and Simons, 2007). For this reason 
and because a high number of cells is needed for a gradient centrifugation the focus was shifted to 
simple detergent extraction followed by pelleting - without performing a flotation gradient. With this 
assay not only wt annexin A2 was analysed but also the phosphorylated protein and several variants 
of this protein harbouring mutations at different sites. 
4.3.2 Influence of Tyr23 phosphorylation and PI(4,5)P2-binding on the association of 
annexin A2 with membrane microdomains 
One of the posttranslational modifications of annexin A2 is the phosphorylation on Tyr23. This residue 
is e.g. phosphorylated by the src kinase of Rous sarcoma virus. This indicates a role of this 
phosphorylation in cellular transformation that recently was verified (de Graauw et al., 2008; Rescher 
et al., 2008). The influence of this phosphorylation of annexin A2 on the association of this protein with 
DRMs was investigated in the following. 
It was shown that in a BHK cell line stably expressing the insulin receptor (IR) annexin A2 is 
phosphorylated after the stimulation of these cells with insulin (Rescher et al., 2008). This 
phosphorylation can also be achieved by incubating the cells with the insulinomimetic agent hydrogen 
peroxide (H2O2) in combination with the phosphatase inhibitor orthovanadate (Na3VO4) (Heffetz et al., 
1992). BHK-IR cells were stimulated with insulin or H2O2 + Na3VO4 and extracted with 1 % 
Triton X-100 on ice. The Triton soluble and insoluble fractions were analysed by western blot analysis 
(Figure 4-19). 
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Figure 4-19: Phosphorylation of annexin A2 does not alter its association with DRMs in BHK-IR 
BHK-IR were serum starved overnight and stimulated with either 5 µg/ml insulin or 17 µM H2O2 + 100 µM 
Na3VO4 for 30 min. The cells were extracted with 1 % Triton X-100 on ice in the presence of 50 nM Ca2+ and the 
Triton soluble fraction (S = supernatant) and the Triton insoluble fraction (P = pellet) were separated via a 
centrifugation step. The proteins were separated on an SDS-PAG and transferred to a PVDF membrane. 
Caveolin was detected as a DRM marker and transferrin receptor as a Triton soluble marker. Phosphorylated 
tyrosine (pTyr) of annexin A2 was detected with the help of the 4G10 platinum antibody and the annexin A2 
antibody from BD Transduction Labs was used to detect total annexin A2. Error bars represent SD from n = 3. 
 
A preferential localisation of caveolin in the Triton insoluble pellet could be detected. Furthermore, the 
transferrin receptor is localised in Triton soluble fractions. These two markers indicate that the 
extraction of BHK-IR with cold detergent was successful in terms of separating different membrane 
domains. The endogenous annexin A2 in these cells shows a preferential localisation in the Triton 
insoluble pellet (about 80 % of the total protein). Annexin A2 is phosphorylated after the stimulation of 
BHK-IR with insulin or with H2O2 in combination with Na3VO4 as can be detected with the help of an 
anti-phosphotyrosine antibody. This phosphorylation does not alter the association of the endogenous 
annexin A2 with DRMs in these cells. 
 
Another approach to investigate the influence of annexin A2 Tyr23 phosphorylation on the DRM 
association of this protein was the analysis of ectopically expressed annexin A2 variants harbouring 
mutations at this residue. The substitution of the tyrosine with the negatively charged residue Glu 
mimics the phosphorylation on the amino acid 23 (YE) (de Graauw et al., 2008; Rescher et al., 2008). 
On the other hand the substitution with the neutral residue Phe (YF) renders this site unable to be 
phosphorylated. In parallel an annexin A2 variant harbouring the amino acid substitution K281A in the 
PI(4,5)P2-binding site was analysed (KA). This substitution has been described to interfere with the 
binding of annexin A2 to PI(4,5)P2 in vitro (Gokhale et al., 2005). The localisations of the mutations in 
the annexin A2 sequence are depicted in Figure 4-20. 
 
Results 50
STVHILCKLSLEGDHSTPPSAYGSVKAY
TNFDAERDALNIETAIKTKGVDEVTIVNILTNRSNAQRQDIAFAYQRRTKKELASALKSALSGHLETVILGLLKT
PAQYDASELKASMKGLGTDEDSLIEIICSRTNQELQEINRVYKEMYKTDLEKDIISDTSGDFRKLMVALAK
GRRAEDGSVIDYELIDQDARDLYDAGVKRKGTDVPKWISIMTERSVPHLQKVFDRYKSYSPYDMLESIRKEVKGDLENAFLNLVQCIQN
RPLYFADRLYDSMKGKGTRDKVLIRIMVSRSEVDMLKIRSEFKRKYGKSLYYYIQQDTKGDYQKALLYLCGGDD
1 29
30 104
175
264
338
105
p11- and Ca2+-binding deficient
Ca2+-binding deficient
p11-binding deficient
PI(4,5)P2-binding deficient
phospho-deficient
phospho-mimicking
function
Jost et al., 1992D161A, E246A, D321ACM
Jost et al., 1997I6E, L7E 
+ D161A, E246A, D321A
PMCM
Thiel et al., 1992I6E, L7EPM
Gokhale et al., 2005K281AKA
Y23FYF
Rescher et al., 2008Y23EYE
referenceaa substitutionanxA2 mutant
A)
B)
265
176
*
 
 
Figure 4-20: Positions of amino acid replacements in the sequence of human annexin A2 
A) The annexin A2 sequence is given in five blocks, representing the N-terminus (upper row) and the four annexin 
repeats. Positions of aa exchanges are indicated by arrows. All annexin A2 mutants used in this thesis contain the 
A65E substitution (asterisk) which reconstitutes the epitope for the monoclonal antibody H28. B) The different 
annexin A2 mutants used in this thesis including the according references are depicted table form. 
 
MDCK II cells are a good model system for epithelial cells since they are able to polarise in vitro. 
Annexin A2 was studied in this cell line before and it appears to be concentrated underneath the 
apical membrane (Gerke and Weber, 1984). Furthermore, Annexin A2 is the major component of the 
Triton X-100 insoluble low-density fraction prepared from MDCK (Harder and Gerke, 1994). The clone 
MDCK-Tet used in this thesis is readily able to polarise on filters and form cysts and therewith reflects 
some of the major characteristics of this cell line. 
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Figure 4-21: DRM association of ectopically expressed annexin A2 is not altered by mutations on Tyr23 or 
in the PI(4,5)P2-binding domain 
MDCK-Tet cells were transfected with plasmids coding for the indicated GFP labelled annexin A2 variants. 24 h or 
48 h after transfection the cells were extracted with 1 % Triton X-100 on ice in the presence of 50 µM Ca2+ and 
the Triton soluble fraction (S = supernatant) and the Triton insoluble fraction (P = pellet) were separated via a 
centrifugation step. The proteins were separated on an SDS-PAG and transferred to a PVDF membrane. 
Caveolin was detected as a Triton insoluble marker and transferrin receptor as a Triton soluble marker with the 
help of specific antibodies. For the detection of endogenous annexin A2 and ectopic annexin A2-GFP variants the 
annexin A2 antibody from BD transduction laboratories and the GFP antibody were used, respectively. Error 
bars represent SD from n  5. 
 
MDCK-Tet cells transiently expressing annexin A2 wt, YE, YF or KA-GFP were extracted with 
Triton X-100 on ice and the DRM association of these variants was analysed (Figure 4-21). About 
60 % of the endogenous annexin A2 in these cells resides in DRM fractions. The same is the case for 
ectopically expressed GFP-tagged annexin A2 wt. Mutations of the Tyr23 phosphorylation site or the 
PI(4,5)P2-binding site do not alter this distribution. 
 
There are also other means to assess the raft association of a protein than detergent extraction. One 
has recently been described by the group of Kai Simons. They showed that rafts of cellular 
membranes are able to coalesce into micrometer-size raft-based phases that can be visualised by 
microscopy. These slower diffusing membrane phases are enriched in cholesterol and raft 
transmembrane proteins like GPI-anchored proteins (Lingwood et al., 2008). To induce these large 
membrane phases cells are incubated overnight with a hypotonic buffer. This cell swelling procedure 
generates membrane preparations called plasma membrane spheres (PMSs) which are separated 
from the underlying cytoskeleton and endo- or exocytotic processes. PMSs appear as a spherical 
membrane outgrowth, 20 - 30 µm in diameter, which are still attached to the remaining cell body. By 
clustering the raft ganglioside GM1 with cholera toxin B (CtxB) at 37 °C raft-based phases, called GM1 
phases, can be induced in these spheres. For this phase induction a high concentration of GM1 is 
critical. Therefore, A431 are a well suitable cell line for this analysis. 
To establish the system of selective GM1 phases in A431 cells, these cells were induced to form 
phase separated PMSs and the localisation of one raft marker and one non-raft marker was analysed. 
As a raft marker the pleckstrin homology domain (PHD) of phospholipase C (PLC)-1 was used. The 
PHD selectively binds PI(4,5)P2 which is enriched in cholesterol rich membrane microdomains (Pike 
and Casey, 1996; Varnai and Balla, 1998). As a non-raft marker the transferrin receptor was used 
which is excluded from raft microdomains (Janes et al., 1999). 
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Figure 4-22: The GM1 phases of PMSs of A431 cells include PI(4,5)P2 and exclude the transferrin receptor 
A431 were transfected with a plasmid encoding a YFP labelled PHD or left untransfected. Spheres were induced 
by the addition of PMS buffer. Clustering of GM1 by CtxB Alexa Fluor 549 leads to the induction of GM1 phases 
to which PHD is recruited as a marker for PI(4,5)P2. The untransfected cells were incubated for 1 h with FITC 
labelled transferrin to visualise the transferrin receptor which is excluded from the CtxB-positive membrane 
phases. Shown are representatives of 5 (for PHD) or 10 (for transferrin) pictures. (scale bars: 5 µm) 
 
A431 cells were transfected with a plasmid coding for a YFP labelled PHD or left untransfected. The 
cells were induced to form phase separated PMSs. The transfected PHD localises to the GM1 phase 
indicating that PI(4,5)P2 as a raft associated phospholipid is recruited to these raft based membrane 
phases in this system. The phase separated PMSs of untransfected cells were incubated with FITC 
labelled transferrin to visualise the transferrin receptor. The membrane-bound transferrin was not 
recruited to the coalesced GM1 phase, indicating that this lateral reorganisation of membrane 
structure was selective in composition (Figure 4-22). 
 
To investigate the association of annexin A2 with these GM1 phases A431 were transfected with GFP-
tagged annexin A2. Also the GFP labelled annexin A2 variants harbouring mutations on Tyr23 (YE 
and YF) or in the PI(4,5)P2-binding site (KA) were analysed (Figure 4-23). Microscopical analysis of 
the phase separated spheres revealed that ectopically expressed annexin A2 localises to the GM1 
phase in PMSs. This association is not influenced by mutations on Tyr23 or in the PI(4,5)P2-binding 
site. 
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Figure 4-23: Annexin A2 wt, YE, YF and KA localise to GM1 phases in PMSs of A431 cells 
A431 were transfected with plasmids coding for the indicated GFP labelled annexin A2 variants. The next day 
cells were incubated with PMS buffer overnight and afterwards induced to phase separate by the addition of 
labelled CtxB. All investigated proteins localise to the CtxB positive membrane phases. Shown are 
representatives of 7 (for wt and YE), 4 (for YF) or 5 (for KA) pictures. (scale bars: 5 µm) 
 
4.3.3 Influence of p11- and Ca2+- binding on the association of annexin A2 with 
membrane microdomains 
Annexin A2 harbours three high affinity Ca2+-binding sites. These type II binding sites were inactivated 
by substituting Asp161, Glu246 and Asp321 by the nonpolar amino acid Ala (Jost et al., 1992). This 
so-called CM mutant shows a greatly reduced affinity for the divalent cation and much higher Ca2+ 
concentrations are needed for half-maximal phosphatidylserine binding in vitro (Jost et al., 1994). 
The N-terminal 14 amino acids of annexin A2 have been shown to be responsible for p11 binding. 
Exchanges of the neutral amino acids Ile6 and Leu7 with the negatively charged residue Glu render 
this protein unable to bind p11. This monomeric annexin A2 mutant was termed PM (Thiel et al., 
1992). 
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To assess the role of Ca2+- and p11-binding for the association of annexin A2 with membrane 
microdomains the CM and the PM mutant were analysed. Also a double mutant PMCM, harbouring 
inactive p11- and Ca2+-binding sites (Jost et al., 1997), was available for these experiments. The 
localisations of the mutations in the annexin A2 sequence are depicted in Figure 4-20. 
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Figure 4-24: An intact p11-binding site of annexin A2 is essential for the DRM association of this protein 
MDCK-Tet were transfected with plasmids coding for the indicated GFP labelled annexin A2 variants. 24 h or 48 h 
after transfection the DRM association of these proteins was analysed by detergent extraction and subsequent 
western blot analysis as described in Figure 4-21. Error bars represent SD from n  5. The statistical significances 
were evaluated by unpaired t-tests. 
 
The annexin A2 variants were transiently expressed in MDCK cells which were extracted on ice with 
Triton X-100 (Figure 4-24). The association of annexin A2 with DRMs is significantly decreased when 
the p11-binding site is inactivated. Mutations in the high affinity Ca2+-binding sites alone do not appear 
to influence the association with the Triton insoluble fraction. 
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Figure 4-25: Annexin A2 PM and CM localise to GM1 phases in PMSs of A431 cells 
A431 were transfected with plasmids coding for the indicated GFP labelled annexin A2 variants. The next day 
cells were incubated with PMS buffer overnight and afterwards induced to phase separate by the addition of 
labelled CtxB. All investigated proteins localise to the CtxB positive membrane phases. Shown are 
representatives of 10 (for PM) or 3 (for CM) pictures. (scale bars: 5 µm) 
 
The localisations of the annexin A2 CM-GFP and PM-GFP variants in phase separated PMSs were 
also investigated (Figure 4-25). Both of the proteins associated with the GM1 phase.  
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All analysed annexin A2 mutants behave as the wt protein in the experiments using phase separated 
PMSs and are recruited to GM1 phases. This is in contrast to the DRM association analysis. In these 
assays p11-binding deficient mutants (PM and PMCM) show a significantly reduced affinity to DRMs in 
contrast to all other annexin A2 variants tested. 
Annexins are Ca2+-dependent proteins. Presumably the Ca2+ concentration in PMSs is rather high 
(Keller et al., 2009). Since cells die upon induction of spheres the membrane integrity is lost and the 
Ca2+ concentration inside the cell can be the same as in the surrounding buffer, i.e. 1.5 mM CaCl2 in 
this case. 
Hence, the elevated Ca2+ concentration could influence annexin A2 characteristics and contribute to 
an altered behaviour of the PM mutant. The Ca2+ concentration in the buffers used for detergent 
extraction can be tightly controlled - in contrast to the Ca2+ levels inside the PMSs. Therefore, 
annexin A2 PM-GFP expressing MDCKs were detergent extracted in the presence of different Ca2+ 
concentrations (Figure 4-26). 
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Figure 4-26: DRM association of endogenous annexin A2 and of p11-binding deficient annexin A2 is 
influenced by different Ca2+ concentrations 
MDCK-Tet were transfected with a plasmid coding for annexin A2 PM-GFP. 48 h after transfection the DRM 
association of this protein was analysed by detergent extraction and subsequent western blot analysis as 
described in Figure 4-21. Different Ca2+ concentrations were added to the extraction buffers as indicated. 
Depicted here is one of two performed experiments. 
 
The association of endogenous annexin A2 of MDCK cells with DRMs is influenced by the addition of 
Ca2+ to the extraction buffers. Elevated Ca2+ concentrations result in an enhanced shift of annexin A2 
to detergent insoluble fractions. The same holds true for an ectopically expressed p11-binding 
deficient mutant of annexin A2. In contrast to endogenous annexin A2 hardly any annexin A2 PM can 
be detected in the Triton insoluble pellet without the addition of Ca2+ to the buffers. With increasing 
Ca2+ concentrations this protein is shifted to the Triton insoluble fraction. However, the fraction of 
annexin A2 PM that localises to the DRMs at 1 mM Ca2+ is by far less than that of the endogenous 
annexin A2. 
4.3.4 Laurdan 2-photon microscopy of annexin A2 expressing cells 
One approach to analyse membrane rafts in cells is Laurdan microscopy. This method is based on the 
model of cellular rafts as ordered membrane phases which float in a disordered environment of non-
raft membranes (Brown and London, 2000). Membrane order can be assessed by the degree of 
packing order, as loosely packed membranes are more polar due to increased penetration of water 
molecules into the lipid bilayer. Laurdan is a lipophilic dye that aligns itself parallel to the hydrophobic 
tails of membrane phospholipids (Figure 4-27 A). It is a polarity-sensitive probe with two excited states 
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and its fluorescence exhibits a 50 nm blue shift in emission with increasing membrane condensation 
thereby allowing the visualisation of membrane fluidity (Gaus et al., 2003). The principle of this 
spectral shift is demonstrated in Figure 4-27 B. 
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Figure 4-27: Principles of Laurdan 
A) Structure of Laurdan and its orientation in a phospholipid layer. B) The Jablonski diagram of Laurdan shows 
the spectral shift of Laurdan emission in different membrane phases. Depending on the surrounding membrane 
order emission of Laurdan can occur from two possible excited states: the locally excited state (LE) in less polar 
environments and the internal charge transfer state (ICT) in more polar environments. An increment in membrane 
polarity results in an increased dipole moment of the molecule and therefore a shift of its emission to longer 
wavelengths. A schematic representation of the corresponding emission maxima peaks of Laurdan in ordered and 
fluid phases is also shown. From Gaus et al., 2006. 
 
To visualise membrane structure, two intensity (I) images of Laurdan between 400 - 460 nm and 
470 - 530 nm are recorded simultaneously, with channel 1 (400 - 460 nm) recording Laurdan in more 
condensed membranes and channel 2 (470 - 530 nm) recording Laurdan in more fluid membranes. 
From the ratio of the emission intensities the so-called Generalised Polarisation (GP) can be 
calculated. The GP value is defined as 
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The GP value as a relative measure for membrane order can theoretically assume values from +1 
(most condensed) to -1 (most fluid). This emission shift of Laurdan in different membrane phases can 
be calculated for each pixel and together with colocalisation studies, the preferential localisation of a 
specific protein in ordered (condensed) / disordered (fluid) domains of the plasma membrane can be 
determined. 
 
The fluorescence of Laurdan was excited with a 2-photon laser. Low energy photons reaching a 
fluorophore at the same time can induce a single photon emission with higher energy in a process 
called multi-photon excitation. The excited Laurdan emits a single photon as if it were excited by a 
single higher energy photon. 
Since the simultaneous absorption of two photons only takes place in the centre of a pulsed laser, only 
the focal plane of interest is excited. This and the fact that photons of a longer wavelength are 
scattered to a reduced extent leads to the fact that a deeper penetration depth can be achieved 
allowing the visualisation of tissue sections. Furthermore, the usage of a longer wavelength of less 
energy leads to a reduced phototoxicity for live cell imaging. Another important advantage of the 
usage of 2-photon microscopy for the excitement of Laurdan is the fact that the photo-bleaching of the 
fluorophore itself is decreased significantly. 
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As a measure for the association of annexin A2 with ordered domains the membrane order at sites of 
the localisation of this protein was investigated. Not only annexin A2 wt but also the phosphorylation 
mutants YE and YF, the PI(4,5)P2-binding deficient mutant KA as well as the p11-binding deficient 
mutants PM and PMCM were analysed. mCherry labelled constructs were used since GFP would 
interfere with the Laurdan emission. 
The tissue culture for microscopy was conducted in the laboratory of Thomas Grewal (Faculty of 
Pharmacy, University of Sydney, Sydney, Australia) and the microscopy was performed in the 
laboratory of Katharina Gaus (Cellular Membrane Biology Lab, Centre for Vascular Research, 
University of New South Wales, Sydney, Australia). MDCK cells were used for this analysis to work 
with the same cell line that was used for detergent extraction experiments. However, not exactly the 
same cell clone was used. 
MDCK-TG cells were transiently transfected with mCherry labelled annexin A2 variants or mCherry as 
a control and labelled with Laurdan as described in Material and Methods. Fixed cells were used for 
Laurdan microscopy. Examples of confocal images of the mCherry fluorescence of the used proteins 
are presented in Figure 4-28. 
 
 
anxA2 wt-mCherry
mCherry
anxA2 YE-mCherry anxA2 YE-mCherry anxA2 KA-mCherry
anxA2 PM-mCherry anxA2 PMCM-mCherry  
 
Figure 4-28: Localisation of different annexin A2 mutants in MDCK 
MDCK-TG cells grown on coverslips were transiently transfected with plasmids encoding mCherry labelled 
variants of annexin A2 (wt, YE, YF, KA, PM or PMCM) or an mCherry encoding control vector. 24 h after 
transfection the cells were fixed, mounted in Mowiol and analysed by confocal microscopy. 
 
Conventional single-photon confocal images were obtained in parallel to 2-photon Laurdan intensity 
images to determine the membrane order in regions of protein localisation. An example for this image 
analysis is depicted in Figure 4-29. 
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Figure 4-29: Membrane order at sites of annexin A2 localisation 
MDCK-TG transiently expressing mCherry labelled annexin A2 wt were labelled with Laurdan and fixed as 
described in Material and Methods. Intensity images of channel 1 (400 - 460 nm), channel 2 (470 - 530 nm) and 
the corresponding GP image are shown in the upper panel. The GP image is presented in greyscale and also in 
pseudo-colours as indicated by the scale illustrating GP values varying from -1 to +1. The confocal image shows 
the fluorescence of mCherry labelled annexin A2. This image was used to determine regions of high fluorescence 
- hence protein localisation - to create a mask in Adobe Photoshop. This mask was layered on top of the 
corresponding GP image to determine the GP value in the regions of protein localisation. 
 
Using the pseudo-coloured GP image, the order of membrane structure becomes visible. Membrane 
rafts represent liquid-ordered domains which are condensed and appear yellow in a pseudo-coloured 
GP image because of their high GP value, whereas non-raft domains are liquid disordered and fluid 
and appear green because of their low GP value. In this case of a resting MDCK cell no distinct 
regions of increased membrane condensation can be seen (Figure 4-29). The confocal image of 
annexin A2 was used to determine the GP values in the regions where the protein is localised by 
creating a mask. Since in the overall GP image no regions of increased membrane condensation can 
be detected the regions with high protein localisation do not show an elevated GP value. 
 
The GP values of regions of protein localisation were determined for all the proteins depicted in Figure 
4-28. The results are shown in Figure 4-30. 
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Figure 4-30: GP values at regions of high expression of mCherry labelled annexin A2 variants in MDCKs 
do not differ 
MDCK-TG ectopically expressing mCherry labelled annexin A2 wt, annexin A2 mutants (YE, YF, KA, PM, PMCM) 
or an mCherry control were labelled with Laurdan, fixed and imaged as described in Material and Methods. GP 
images and confocal images at identical focal planes were used to determine the GP value at sites of protein 
localisation as described in Figure 4-29. About 30 cells were analysed per experiment and two independent 
experiments were performed that are both demonstrated in this diagram. The means are indicated by horizontal 
lines. 
 
The pseudo-coloured GP image in Figure 4-29 showed no regions with increased membrane 
condensation. The same was true for the masked GP image. When mCherry labelled annexin A2 
variants were used to mask the GP images no domains of increased or decreased membrane order 
could be detected either as seen in Figure 4-30. 
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5 Discussion 
5.1 Annexin A2 in IAV infection 
The pathogenic virus influenza A causes pandemic and epidemic outbreaks on a periodical basis that 
still claim many lives. The so-called Spanish flu caused by an H1N1 virus was responsible for the 
deaths of even at least 40 million people in 1918/1919 (Horimoto and Kawaoka, 2005). Like other 
viruses IAV is an obligate intracellular pathogen. Its replication dependents on a variety of intracellular 
processes. For IAV these processes involve actin dynamics, a range of transport processes and the 
organisation of membrane rafts. Those rafts define the assembly and budding site of influenza. Raft-
lipid domains are selectively incorporated into the influenza virus envelope (Scheiffele et al., 1999) and 
the envelope glycoproteins HA and NA preferentially cluster in membrane rafts of polarised and non-
polarised cells (Scheiffele et al., 1997). Cholesterol depletion of either the host cell or the virus with 
methyl--cyclodextrin interferes with influenza replication (Barman and Nayak, 2007; Sun and 
Whittaker, 2003). 
Defining the cellular proteins and mechanisms involved in influenza A replication might help in finding 
agents to fight this pathogen. Annexin A2 is a possible candidate that could be important for IAV 
infection. Annexin A2 is a multifunctional protein involved in several biological processes. One of its 
key features is the regulated binding to negatively charged phospholipids. This binding property 
accounts for its involvement in membrane organisation and trafficking. It is located on endosomal 
compartments and it promotes membrane fusion during Ca2+-regulated exocytosis (for reviews, see 
Gerke and Moss, 1997 or Gerke et al., 2005). Annexin A2 has been described to bind the cytoplasmic 
site of PI(4,5)P2-enriched membrane microdomains, thereby stabilising these domains and linking 
them to the cortical actin cytoskeleton (Rescher and Gerke, 2004). The actin aggregating effect of 
annexin A2 is implicated to be of importance for the actin rearrangements induced by 
enteropathogenic and enterohemorrhagic E. coli (Miyahara et al., 2009; Zobiack et al., 2002). Other 
pathogens also depend on this host cell protein for efficient replication. E.g. annexin A2 has been 
described to act as a receptor of HCMV (Wright et al., 1994) or respiratory syncytial virus (Malhotra et 
al., 2003). 
Therewith, annexin A2 is involved in numerous processes that are of importance for the IAV replication 
cycle, namely membrane domain organisation, transport processes and actin dynamics. This implies a 
potential role of annexin A2 in IAV replication. Therefore, a closer look was taken at a possible 
involvement of annexin A2 in this process. However, from the experimental data obtained in this thesis 
an active involvement of annexin A2 in influenza A replication cannot be concluded. 
 
First, the number of infectious virus particles in the supernatant of infected annexin A2 manipulated 
cells was determined. No difference in the virus replication could be detected. The virus titres deviated 
in the range of variations that are normal for viral infection experiments. No tendency to either an 
enhanced or a reduced viral replication could be detected, independent of the replication time or the 
virus titre used.  
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In the first experiments cells were depleted for annexin A2 by means of siRNA or manipulated by the 
expression of a mutant annexin A2 protein causing the aggregation of annexin A2 and its ligand p11. 
These methods deplete cytosolic annexin A2 but they hardly affect the membrane bound form 
(Zobiack et al., 2003) since this population is somewhat shielded and has a longer half life (Zokas and 
Glenney, 1987). The virus infection experiments were also performed with cells devoid of annexin A2, 
i.e. CMECs from the annexin A2 knockout mouse, and compared to the replication in cells of a wt 
mouse, but no significant difference in influenza A replication could be detected. 
The fact that no tendency to an altered virus replication could be detected in cells with different 
annexin A2 levels is astonishing taking into account that the cells showed different morphological 
changes reflecting a different onset of apoptosis. Annexin A2 depleted cells were more apoptotic as 
could be determined not only by visual observations but also by the detection of PARP cleavage by 
western blot analysis (discussed below). Influenza viruses induce apoptosis in infected cells. On the 
one hand this is a host mechanism to limit virus spread but on the other hand IAV has taken 
advantage of some of the apoptotic processes to efficiently replicate. E.g. activation of caspase-3 is 
essential for the nuclear export of viral RNP complexes (Wurzer et al., 2003). 
The influenza virus might possibly take advantage of early apoptotic events of, such as caspase-3 
activity, while the full execution of the apoptotisis leads to a diminished cell number. A reduction of the 
cell number results in the fact that the remaining virus meets a decreased number of cells to replicate, 
which may result in reduced end titres (Wurzer et al., 2003). Therefore, an either reduced or an 
enhanced virus replication would be expected in annexin A2 depleted cells since they are more 
apoptotic. This is neither the case for early nor for late time points p.i.. The reason for this discrepancy 
remains to be determined. 
 
It has to be taken into account that the cells used for these influenza infection experiments were not 
polarised. In polarised cells annexin A2 appears concentrated underneath the apical membrane 
(Gerke and Weber, 1984). This apical side of polarised cells also defines the site of influenza virus 
entry and exit. The behaviour of influenza virus in polarised cells might differ from that in non-polarised 
cells. E.g. it has been reported that a dynamic actin cytoskeleton is indispensable for influenza virus 
entry into polarised epithelial cells, but not for non-polarised cells (Sun and Whittaker, 2007). However, 
a depletion of annexin A2 prevents normal development of the apical surface (Martin-Belmonte et al., 
2007) and cells that already established an apical-basolateral polarity are almost impossible to 
transfect. 
 
This objection also holds true for the experiments that were performed to analyse the surface 
localisation of influenza HA. Annexin A2 has been described to be essential for the apical transport of 
the raft associated protein sucrose isomaltase in polarised MDCKs (Jacob et al., 2004). Nevertheless, 
to our knowledge no such analysis was performed in non-polarised cells. Membrane trafficking in 
polarised cells differs from non-polarised cells (Tuma et al., 2002). In polarised cells as well as in non-
polarised cells influenza HA is readily transported to the plasma membranes to regions that are 
resistant to the extraction with non-ionic detergents (Skibbens et al., 1989). However, the proteins 
being involved in these transport processes might differ profoundly. Therefore, an involvement of 
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annexin A2 in the apical transport of influenza HA cannot be excluded. At least, this protein does not 
have an impact on the surface HA transport in non-polarised A549 cells. 
 
Quantitative real-time PCR analysis was performed on PR8 infected cells and the mRNA level of 
annexin A2 and annexin A1 were determined. The latter was included since it is involved in host 
immune response and cellular proliferation (Lim and Pervaiz, 2007). However, IAV does not seem to 
alter the mRNA levels of these two annexins. No difference can be seen in the mRNA levels of PR8 
infected HeLa, A549 or HepG2 cells when they were compared to uninfected cells. 
 
Double immunofluorescence labelling was carried out to investigate a possible colocalisation of 
annexin A2 with influenza particles in infected cells. For this analysis A549 were infected with avian 
influenza FPV. 30 min p.i. the antibody decorates dot like structures close to the cellular surface which 
probably resemble endosomes. These structures are more distributed throughout the cytosol 1 h or 
2 h p.i., indicating that the virus containing endosomes approach the nucleus where the viral RNA is 
released. At late time points the fluorescence increases due to newly synthesised influenza proteins. 
This protein concentrates at the plasma membrane from where finally new virus particles can bud. 
Thus, with the antibody used for this immunofluorescence staining some of the major hallmarks of 
influenza virus replication could be visualised. At none of these time points a colocalisation with either 
cytosolic or membrane bound annexin A2 could be seen. However, with the fixation technique used 
here the endosomal localisation of annexin A2 could not be visualised. 
 
Even though no colocalisation of FPV with annexin A2 in influenza infected cells could be seen, an 
incorporation of this host cell protein into purified virions could be detected. The NS1 protein was not 
detectable in the purified virus fraction indicating that the detected annexin A2 does not result from 
contaminations by cellular remnants. Annexin A2 has been described to be incorporated into a whole 
range of enveloped virus particles, like HIV-1 (Harrist et al., 2009), herpes simplex virus 1 (Loret et al., 
2008; Padula et al., 2009), vesicular stomatitis virus (Moerdyk-Schauwecker et al., 2009), vaccinia 
virus (Chung et al., 2006), alcelaphine herpesvirus-1 (Dry et al., 2008; Zhu et al., 2005), Kaposi’s 
sarcoma-associated herpesvirus (Zhu et al., 2005) and HCMV (Wright et al., 1995). The fact that 
annexin A2 incorporation into virus particles is so common indicates that annexin A2 could play a 
general role in the infection process of enveloped viruses. 
The group of Béatrice Riteau also found annexin A2 to be associated with influenza A virions. They 
hypothesised that this protein is actively involved in promoting IAV infection by being involved in the 
proteolytic activation of influenza HA (LeBouder et al., 2008). Annexin A2 and p11 were identified in 
purified virus particles by western blot analysis and the presence of annexin A2 was confirmed by 
immunogold labelling and subsequent electron microscopy. LeBouder and coworkers describe that the 
ability of annexin A2 to activate plasminogen could be of importance for IAV infection. Plasmin might 
serve as a trypsin-like protease that cleaves influenza HA. The activation of this protein by cleavage is 
essential for influenza virus infection. Therefore, annexin A2 mediated activation of plasminogen might 
support the replication of influenza viruses which may contribute to their pathogenicity (LeBouder et 
al., 2008). 
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Recently, a mass spectrometry approach of influenza virus particles was performed by the group of 
Peter Palese. 36 host-encoded proteins including annexin A2 were detected (Shaw et al., 2008). 
Annexin A2 could also be identified by western blot analysis of purified virions. The annexin A2 protein 
amount of subtilisin protease treated virions does not seem to be decreased when compared to 
untreated virions. This reveals that annexin A2 is - at least partly - localised inside the virion. But it has 
to be taken into account that the purification buffers contained 1 mM EDTA. Chelation of Ca2+ ions 
results in the removal of surface bound annexin A2 (Falcone et al., 2001) so it would not be detected 
any more in this analysis. Therefore, these data do are not sufficient confirm that annexin A2 is 
localised on the surface of influenza virus particles where it might possibly be involved in plasminogen 
activation (LeBouder et al., 2008). 
Hence, the observation in this thesis that annexin A2 is incorporated into influenza A virus particles is 
in accordance with recently published data. However, an involvement of annexin A2 in the 
plasminogen conversion (LeBouder et al., 2008) could not be validated. Cells died upon application of 
plasminogen. HepG2, A549 and MDCK were used for these experiments (data not shown). The onset 
of cell death was probably due to uncontrolled plasminogen activation on the cell surface. This 
presumably results in the proteolysis of fibronectin and lamin, which is followed by cell detachment 
and apoptosis (Rossignol et al., 2004). The group of Béatrice Riteau also used MDCK cells. 
Nevertheless, discrepancies could arise from the well-known heterogeneities in specific cell clones in 
the various laboratories. 
In the work performed here the purification of influenza virions was rather problematic. Only one of 
many virus preparations did not show detectable amounts of influenza NS1 which was used to detect 
contaminations by cellular debris. NS1 is only produced in infected cells but not incorporated into the 
virus particle. Since the purification of the virions quite often was not successful and the incorporation 
of annexin A2 has been demonstrated in the meantime by two different working groups the purification 
and further characterisation of purified virus particles was not pursued any further. However, it would 
be interesting to detect if the annexin A2 in the influenza virus particles harbours posttranslational 
modifications or is indeed localised on the surface of the virion. 
 
Shaw and colleagues not only identified annexin A2 in influenza A particles but also annexin A1, 
annexin A4, annexin A5, annexin A11 and S100A11, which is a binding partner of annexin A1 and 
annexin A2 (Shaw et al., 2008). However, the incorporation of the S100 protein p11, as a major 
binding partner of annexin A2, was not described in this study. This is in contrast to the observations 
by LeBouder and co-workers who detected p11 in purified influenza A particles by western blot 
analysis (LeBouder et al., 2008). 
A role of annexin A5 in influenza virus infection has been discussed before. In general IAV binds sialic 
acid containing receptors on the cell surface (for a review, see Dimmock, 1982). Otto and co-workers 
found a sialic acid-free cellular protein that binds IAV. They identified this protein to be annexin A5. A 
role of this protein in influenza A entry was hypothesised (Huang et al., 1996; Otto et al., 1994). 
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5.2 Annexin A2 in apoptotic processes 
Annexin A2 appears to be a key regulator of cellular proliferation (Chiang et al., 1999). An involvement 
of annexin A2 in cellular transformation has been hypothesised ever since the initial identification of 
this protein as a major substrate of the tyrosine kinase pp60v-src (Radke et al., 1980). By now it could 
be shown that the tyrosine phosphorylation at position Tyr23 in the N-terminal domain is involved in 
the reorganisation of the membrane-associated actin cytoskeleton during cellular transformation (de 
Graauw et al., 2008; Rescher et al., 2008). Furthermore, Yamada and colleagues demonstrated that 
the annexin A2/p11 complex is involved in the formation of the E-cadherin-based adherent junctions in 
MDCK cells, which itself is important for cell migration (Yamada et al., 2005). 
It could be shown that annexin A2 is overexpressed in acute myeloid leukaemia (Menell et al., 1999), 
brain tumours (Roseman et al., 1994), breast cancer (Sharma et al., 2006), pancreatic cancer 
(Esposito et al., 2006) and gastric cancer (Emoto et al., 2001). Since annexin A2 is a receptor for 
tissue plasminogen activator and thereby is involved in the activation of plasminogen (Hajjar and 
Krishnan, 1999), extracellular annexin A2 might activate the fibrinolytic system associated with cancer 
metastasis. The annexin A2 knockout mouse shows microvascular fibrin accumulation, stressing the 
fact that annexin A2 is important for fibrinolysis. Moreover, the directed migration of endothelial cells 
from the annexin A2 knockout mouse through fibrin and collagen lattices was reduced in vitro (Ling et 
al., 2004). This is in accordance with a possible positive correlation of annexin A2 with cancer 
metastasis. 
Furthermore, annexin A2 down-regulation by siRNA can inhibit the proliferation and the invasive 
potential of Jurkat cells remarkably (Bao et al., 2009b) and in multiple myeloma cell lines the depletion 
of this protein resulted in a decreased proliferation and invasive potential and an increased apoptosis 
of the cells (Bao et al., 2009a). An up-regulation of annexin A2 in cancer cells might therefore protect 
them from apoptosis. 
 
An increased sensitivity towards apoptosis-inducing agents upon annexin A2 depletion was also 
observed during the course of this thesis using different cell lines. The apoptotic stimuli used here 
included the IAV strains PR8 and FPV, staurosporine and TNF. But also transfection stress was 
sometimes sufficient to induce apoptosis. The differences in apoptosis progression were visualised by 
the detection of cleaved PARP which is a direct substrate of the major executive caspase-3. Also the 
activation of upstream initiator caspases-8 and -9 was determined in staurosporine and TNF treated 
HeLa cells. 
TNF is an initiator of the receptor mediated extrinsic apoptotic pathway. Since it has been described 
that the extrinsic pathway converges with the intrinsic pathway through the activation of Bid by 
caspase-8 (Li et al., 1998) it is not astonishing that also caspase-9 is found to be activated after the 
stimulation of cells with TNF. 
Staurosporine was used as an activator of the mitochondrial caspase-dependent apoptotic pathway 
including caspase-9 (Scarlett et al., 2000). In the experiments performed here staurosporine treatment 
of HeLa cells also resulted in an increase in the cleavage of caspase-8. It has been demonstrated 
before that caspase-8 can be activated in the absence of death receptor signalling (Wesselborg et al., 
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1999). In a macrophage cell line the treatment with staurosporine induced an increase in TNF levels 
which led to the activation of caspase-8 by an autocrine effect of TNF (Nakamura-Lopez et al., 
2009). Furthermore, caspase-8 has also been described to be activated in the context of staurosporine 
induced-apoptosis in cells derived from human cervical cancer and it is hypothesised that the initiator 
caspases are cell specific (Nicolier et al., 2009). Therefore, it is not astonishing that in the experiments 
performed here, using the cervical cancer cell line HeLa, the treatment of cells with staurosporine also 
resulted in the activation of the extrinsic apoptotic pathway involving caspase-9. 
Independent of the apoptotic stimulus used for these experiments (i.e. staurosporine or TNF) the 
initiator caspases-8 and -9 were activated. This activation seems to be quite simultaneous, stressing 
the fact that the extrinsic and intrinsic apoptosis-inducing pathways cannot be fully separated. The fact 
that both, caspase-8 and -9, are activated to a larger extent in annexin A2 depleted cells indicates that 
the influence of annexin A2 on the onset of apoptosis cannot be directly linked to either of the two 
caspases. 
 
Annexin A2 has been described in the context of apoptosis before. As mentioned above down-
regulation of this protein results in an increased apoptosis rate of multiple myeloma cells (Bao et al., 
2009a). In renal cell carcinoma cells annexin A2 depletion leads to a decrease in proliferation resulting 
in apoptosis (Tanaka et al., 2004) and it was reported that the depletion of annexin A2 renders cells 
more susceptible to UVC-induced cell death (Tong et al., 2008). Furthermore, it was shown that 
annexin A2 may be involved in cellular apoptosis induced by p53, one of the best studied tumour 
suppressor genes. Annexin A2 is down-regulated in human lung carcinoma cells expressing p53, 
especially in cells with high metastatic potential which are more sensitive for p53-induced apoptosis 
(Huang et al., 2005; Huang et al., 2008). However, there is also evidence that annexin A2 is 
overexpressed in response to the overexpression of the p53 gene in human glioblastoma cells (Saffari 
et al., 2009). Discrepancies between these observations could be based on the different cell systems 
used. 
A regulation of the p53 gene in influenza infected cells has also been described. p53 protein levels as 
well as p53 dependent gene transcription are up-regulated upon influenza virus infection in mouse 
embryo fibroblasts and human lung cells including A549 (Turpin et al., 2005) as well as in MDCK and 
Vero cells (Shen et al., 2009). Surprisingly, viral replication was elevated in cells with inhibited p53 
activity, which might be a result of a decreased interferon response (Turpin et al., 2005). 
p53 accumulation in TNF treated apoptotic sensitive cells was reported for human cervical cancer 
cells (Donato and Perez, 1998) and human breast cancer cells (Jeoung et al., 1995). And also after 
staurosporine treatment the p53 protein level was described to be up-regulated in mouse 
neuroblastoma / rat glioma hybrid cells (Zhang et al., 2003). By contrast, a down-regulation was 
observed in a mouse sarcoma cell line (Zong et al., 1999) pointing to a cell type specific involvement 
of p53 in staurosporine mediated apoptotic responses. 
The p53 status of influenza A infected cells or of cells treated with staurosporine or TNF was not 
determined. Therefore, no conclusion can be drawn concerning a possible correlation of p53 and 
annexin A2 in the apoptotic processes described in this thesis. 
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The protein level of annexin A2 in PR8 infected cells in comparison to non infected cells was unaltered 
as could be seen by western blot analysis. Furthermore, real-time PCR analysis of PR8 infected HeLa, 
A549 or HepG2 did not reveal a regulation of the corresponding mRNAs in response to virus infection. 
The protein level of annexin A2 was not altered in staurosporine or TNF treated cells either. And also 
no cleavage of this protein was detectable. This is in contrast to the observations of Wang and co-
workers. They detected that after apoptosis induction annexin A2 is time-dependently cleaved (Wang 
et al., 2009). They analysed serum withdrawal-induced cell cycle inhibition and anticancer drug-
induced apoptosis in different cell lines. Hence, the apoptotic stimuli differ from those used in this 
thesis which could possibly result in the different observations. 
 
Annexin A2 harbours a nuclear export signal suggesting a function of this protein in the nuclear 
compartment (Eberhard et al., 2001). It has been identified as part of the primer recognition complex 
that interacts with DNA polymerase  and it enhances the activity of this complex in vitro (Jindal et al., 
1991). It has been shown that annexin A2 is involved in DNA replication in Xenopus egg extracts, 
demonstrating that annexin A2 is indeed involved in DNA replication and plays a role in the cell cycle 
of higher eukaryotes (Vishwanatha and Kumble, 1993). Treatment of HeLa cells with antisense 
oligonucleotides to annexin A2 reduces DNA synthesis and retards progression through the cell cycle 
(Chiang et al., 1999; Kumble et al., 1992). No influence on cellular proliferation upon siRNA 
transfection was visible in the experiments performed here. Nevertheless, it is possible that 
impairment in cell cycle progression might eventually lead to the observed enhanced sensitivity 
towards apoptosis induction in annexin A2 depleted cells.  
The activity of annexin A2 as an mRNA binding protein might also be of importance for its involvement 
in apoptotic processes. One mRNA that is bound by this protein is that of c-Myc (Mickleburgh et al., 
2005). The proto-oncogene c-Myc codes for a transcription factor that is involved in various cellular 
processes, like cell growth, proliferation, inhibition of terminal differentiation and apoptosis. This 
protein is activated in a variety of human tumours (Pelengaris et al., 2002). Transfection of LNCaP 
cells with annexin A2 resulted in up-regulation of c-Myc protein (Filipenko et al., 2004). Hence, a 
deregulation of c-Myc could possibly be responsible for the increased sensitivity towards apoptotic 
stimuli in annexin A2 depleted cells. 
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5.3 Annexin A2 association with membrane microdomains  
5.3.1 DRM association of annexin A2 mutants 
The lateral organisation of membranes plays a crucial role in many cellular events. This organisation 
arises from preferential packing of sphingolipids and cholesterol into membrane microdomains, so-
called lipid rafts (Simons and Ikonen, 1997). These microdomains serve as platforms for multiple 
cellular processes by the recruitment and concentration of molecules. They are involved in membrane 
sorting and signal transduction and they also play an important role in the replication of several 
pathogens. E.g. mammalian viruses like influenza, human immunodeficiency virus (HIV), measles and 
ebola bud from membrane rafts (Manes et al., 2003; Simons and Ikonen, 1997; Simons and Toomre, 
2000). The resistance of proteins to detergent extraction in the cold is widely used as a criterion for the 
association of these proteins with membrane rafts in living cells (Brown and London, 1998). 
Annexin A2 has been described to be associated with membrane rafts and is involved in the 
stabilisation and aggregation of these domains. It binds to negatively charged phospholipids in the 
membrane in a Ca2+-regulated manner and by lateral segregation is specifically recruited to PI(4,5)P2 
containing membrane rafts (Rescher and Gerke, 2004). Furthermore, annexin A2 binds to cholesterol 
enriched microdomains in a Ca2+-independent way (Harder et al., 1997). The capability of annexin A2 
to self aggregate on membranes could promote the aggregation of raft microdomains (Menke et al., 
2004). 
In the experiments performed here phosphorylated annexin A2 and different annexin A2 mutants were 
employed to investigate which features of annexin A2 are important for the association of this 
molecule with membrane microdomains which could also be relevant for pathogen infections. 
Therefore, the resistance to detergent extraction on ice was analysed. 
 
First, the impact of the phosphorylation on Tyr23 was analysed. Recently, a link was drawn to directly 
relate Tyr23 phosphorylation to cellular transformation. Expression of the phospho-mimicking 
annexin A2 mutant Y23E itself was sufficient to induce actin rearrangement and cell scattering in 
MDCK cells (de Graauw et al., 2008). Furthermore, this phosphorylation of annexin A2 leads to the 
reorganisation of membrane-associated actin cytoskeleton resulting in a loss of cell substratum 
contact in BHK cells overexpressing the insulin receptor (Rescher et al., 2008). This actin remodelling 
probably results from an up-regulation of the Rho/ROCK pathway. Rho is a small GTPase and is a key 
regulator of the cytoskeletal remodelling required for cell spreading, motility and cell-shape changes 
(for a review, see Ridley, 2001). ROCK is a serine/threonine kinase acting as an effector of Rho 
(Riento and Ridley, 2003). The direct interaction of annexin A2 with another Rho protein, namely 
Cdc42, and its implication for cellular functions has been demonstrated before (Martin-Belmonte et al., 
2007). 
The phosphorylation of annexin A2 might also alter its ability to act as a membrane-cytoskeleton linker 
or membrane domain organiser (Rescher et al., 2008). There is evidence that tyrosine phosphorylation 
of annexin A2 inhibits the ability of this protein to bind to and bundle F-actin (Hubaishy et al., 1995). 
To specifically analyse the association of Tyr23 phosphorylated annexin A2 with DRMs BHK-IR were 
stimulated with either insulin or H2O2 in combination with Na3VO4. These stimuli lead to a 
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phosphorylation of annexin A2 on Tyr23 (Heffetz et al., 1992; Rescher et al., 2008). Furthermore, 
ectopically expressed phosphorylation mutants were analysed in MDCK. The annexin A2 YE mutant 
mimics the phosphorylation of amino acid 23 and annexin A2 YF cannot be phosphorylated on this 
residue any more. Using these two different approaches no influence of the Tyr23 phosphorylation on 
the resistance to detergent extraction in the cold could be detected. 
Powell and Glenney analysed the binding of annexin A2 to phosphatidylserine liposomes and 
observed a reduced affinity upon phosphorylation on Tyr23 (Powell and Glenney, 1987). However, 
cellular membranes are more complex than liposomes and a whole range of molecules can contribute 
to the association of proteins with membranes and in this case with membrane microdomains that are 
resistant to detergent extraction in the cold. Therefore, Tyr23 phosphorylation of annexin A2 seems 
not to be of regulating importance for the association of this protein with cellular membrane rafts. 
However, it has to be taken into account that the analysed annexin A2 derivatives are still able to bind 
p11. Therefore, a localisation to DRMs might be mediated by forming mixed heterotetramers with 
endogenous annexin A2 and p11. 
 
One key feature of annexin A2 that is thought to contribute to raft organisation is the ability to bind 
PI(4,5)P2 (Gokhale et al., 2005). PI(4,5)P2-binding proteins can be divided into two groups. The first 
group contains a structurally defined module responsible for the binding to this phospholipid, e.g. a 
pleckstrin homology domain. The second group does not harbour such a distinct domain but is 
characterised by clusters of basic residues of relatively undefined structure that are capable of 
mediating PI(4,5)P2 binding (McLaughlin et al., 2002). Such cationic residues have also been 
identified in annexin A2 and the mutation of either Lys279 or Lys281 to Asp resulted in a remarkably 
decreased affinity for plasma membrane mimetic vesicles of the respective bacterially expressed 
monomeric proteins. Furthermore, annexin A2 mutants harbouring these mutations are not able to 
cluster PI(4,5)P2 on giant unilamellar vesicles any more (Gokhale et al., 2005). The annexin A2 
derivative KA harbouring a substitution at Lys281 was analysed for its association with cellular 
membrane microdomains. 
DRM analysis revealed that the ectopically expressed KA mutant showed the same resistance to 
detergent extraction as ectopically expressed wt annexin A2 in MDCKs. Hence, the basic Lys281 that 
is supposed to be essential for PI(4,5)P2-binding and -clustering in vitro does not have a major impact 
on the resistance of annexin A2 to detergent extraction in the cold. Different subsets of membrane 
rafts exist. Some of these possess a reduced level of PI(4,5)P2. Binding to these domains can be 
mediated by other interactions of annexin A2 and possibly result the DRM association seen in these 
experiments. Furthermore, and as mentioned above, in living cells interaction mechanisms might be 
much more complex. Cellular membranes are not only composed of lipids but also of a variety of 
proteins and also the cellular cytoskeleton underneath the plasma membrane contributes to 
membrane architecture. Therefore, interactions might not be limited to a single amino acid. Maybe a 
double or triple mutant harbouring more mutations in the PI(4,5)P2 binding site might show a reduced 
binding to DRMs in this system. Possible candidates for these mutations would be Lys279 and Arg284 
that present two further conserved cationic residues in the putative PI(4,5)P2-binding region of 
annexin A2. The substitution of Lys279 with Ala has already been demonstrated to interfere with the 
capability of annexin A2 to bind to and cluster PI(4,5)P2 in vitro (Gokhale et al., 2005). However, also 
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in the case of the annexin A2 KA mutant it has to be taken into account that this protein could still be 
recruited to DRMs by mixed heterotetramers in which a p11 dimer links the derivative to endogenous 
intact annexin A2. 
 
Ca2+-binding is one of the most prominent characteristics of annexins. Annexin A2 harbours three high 
affinity type II Ca2+-binding sites and two type III Ca2+-binding sites. Inactivation of the type II sites 
results in the so-called CM mutant that shows a remarkably reduced affinity for the divalent cation and 
requires much higher Ca2+ concentrations for half-maximal phosphatidylserine binding (Jost et al., 
1994). In the experiments performed in this thesis about 60 % of ectopically expressed annexin A2 CM 
and also about 60 % of annexin A2 wt associate with DRMs. Therefore, this mutation does not 
interfere with detergent resistance in the cold. 
The group of David M. Waisman report that heterotetrameric annexin A2 CM Ca2+-independently 
binds to phospholipids and F-actin. They propose that the inactivation of Ca2+-binding sites by site-
directed mutagenesis results in a conformational change that promotes binding to anionic 
phospholipid and F-actin (Filipenko et al., 2000). This could be a possible explanation for an 
association of the CM mutant with DRMs. 
However, it is also known that annexin A2 can Ca2+-independently bind to membranes (Jost et al., 
1997), especially of those harbouring high amounts of cholesterol (Harder et al., 1997; Zeuschner et 
al., 2001). Therefore, the observed association of annexin A2 with DRMs might result from Ca2+-
independent membrane binding sites that have not been characterised yet. Furthermore, also the CM 
mutant could be localised to DRMs by forming mixed heterotetramers with p11 and endogenous 
annexin A2. 
 
Many annexin A2 functions can be attributed to its heterotetrameric form with p11 (Gerke, 1989). 
Monomeric annexin A2 is reported to need higher Ca2+ concentrations for binding to phospholipids 
and membranes (Evans and Nelsestuen, 1994). DRM association analysis revealed that also the 
resistance to detergent extraction is altered. Only about 10 % of monomeric annexin A2 mutants 
incapable of binding p11 localised to detergent resistant fractions, in contrast to 60 % of the wt protein. 
Therefore, p11-binding is essential for the association of annexin A2 with DRMs. 
The experiments were performed using 50 µM Ca2+ in the extraction buffers. Since it has been 
described that monomeric annexin A2 needs an increased amount of Ca2+ to bind phospholipids also 
the association with DRMs at higher Ca2+ concentrations was analysed. Indeed, the p11-binding 
deficient mutant of annexin A2 was shifted to the Triton insoluble fraction at higher Ca2+ 
concentrations (up to 1 mM). This indicates that not only the general phospholipid binding of the 
annexin A2 monomer requires a high amount of Ca2+ but also its association with membrane 
microdomains that are resistant to detergent extraction in the cold. This is in accordance with results 
obtained by Eberhard and co-workers. They worked with an N-terminally GFP-tagged annexin A2 
construct which was unable to form heterotetrameric complexes with endogenous p11 and 
annexin A2. In their experiments endogenous annexin A2 associated with the Triton insoluble fraction 
at 100 µM Ca2+, whereas the monomeric GFP-tagged annexin A2 was not detected in this fraction 
below 1 mM Ca2+ (Eberhard et al., 2001). 
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The ability to form heterotetramers might also be of critical importance for the association of the other 
annexin A2 derivatives tested here, as already mentioned above. They still possess an active p11-
binding site and this might enable them to be recruited to membrane microdomains by forming mixed 
heterotetrameric complexes with endogenous annexin A2 and p11. It would be interesting to analyse 
these proteins in a cell system devoid of endogenous annexin A2. It is striking that only the proteins 
harbouring mutations in the p11-bindings sites (i.e. PM and PMCM) lost the ability to bind to detergent 
resistant membranes at somewhat physiological Ca2+ concentrations. Therefore, it is tempting to 
speculate that the p11-binding is of critical importance for the association of annexin A2 with 
membrane rafts in living cells. 
 
However, DRMs are products of an artificial aggregation process and cannot be considered 
physiological membrane rafts. Resistance to extraction by detergents, most prominently Triton X-100, 
at 4 °C is widely used as a defining criterion for rafts and raft-association of cellular proteins and lipids 
(Brown and London, 1998). While the analysis of association to DRMs has been a valuable entry point 
for the raft research area, the concept of equating DRMs with raft membrane microdomains of cells 
has been criticised (Munro, 2003). From studies in model membranes (Heerklotz, 2002) and isolated 
cellular membranes (Gaus et al., 2005) it turned out that the detergent treatment itself can induce the 
formation of membrane domains which do not exist in the membranes prior to detergent extraction. 
Hence, detergent-resistant membranes should not be assumed to resemble biological rafts in size, 
structure or composition. Therefore, there is need for other experimental approaches to analyse these 
membrane microdomains. 
5.3.2 Localisation of annexin A2 in the GM1 phase of PMSs 
Model membrane systems, including giant unilamellar vesicles, allow optical discrimination of 
coexisting lipid phase types. But the cellular plasma membrane is very dynamic, has a complex 
protein and lipid composition and is connected to the underlying cytoskeleton. This complexity might 
prevent fluid phase segregation into optically resolvable microdomains that is seen in artificial 
membrane vesicles. 
However, two recent studies demonstrated that microscopic phase separation can occur in cellular 
membranes under certain conditions. Baumgart and co-workers used chemical membrane blebbing to 
generate giant plasma membrane vesicles (GPMVs) that separate into micrometer-scale fluid phase 
domains upon cooling. These domains represent lo-like and ld-like phases as identified by fluorescent 
probes (Baumgart et al., 2007). In another approach Lingwood and colleagues used a hypotonic cell 
swelling procedure to generate membrane preparations called plasma membrane spheres (PMSs). By 
addition of CtxB phase separation was induced by clustering of the raft ganglioside GM1 at 37 °C. The 
emerging GM1 phase is enriched in cholesterol and transmembrane and lipid-anchored raft proteins 
(Lingwood et al., 2008). Both of these membrane outgrowths are devoid of actin cytoskeletal influence 
and endo- and exocytotic processes. Presumably, this uncoupling from the underlying cytoskeleton 
allows the coalescence of large-scale raft-based phases (Baumgart et al., 2007). 
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The association of annexin A2 and annexin A2 derivatives with the GM1 phase of PMSs was 
analysed. All annexin A2 variants tested localised to the CtxB positive membrane phase, indicating 
that the mutations applied here do not alter the binding to the large-scale raft-based phases of PMSs. 
 
Thus, there is a discrepancy between the association of the p11-binding deficient annexin A2 mutant 
to the GM1 phase of PMSs and the observed reduced binding of this mutant to DRMs. In this context it 
is important to remember that detergent extraction only produces an artificial coalescence of proteins 
and lipids into a fraction that is enriched in raft proteins and raft lipids. Triton X-100 is quite a strong 
detergent and is thought to disrupt weak associations of proteins to rafts. For an association with the 
GM1 phase in PMSs probably only a weak or transient association with this raft-based membrane 
phase is sufficient for the protein to be clustered into a more stable platform upon glycolipid or protein 
oligomerisation (personal communication with Daniel Lingwood, Dresden, Germany). Therefore, it 
might be possible that monomeric annexin A2 displays a weak association with cholesterol rich 
microdomains that might be destroyed by detergent extraction in the cold. However, it has to be noted 
that the system of the phase separation in PMSs is not characterised very well either and extrapolating 
these membrane phases to living cell membranes should be considered with caution. 
 
One other explanation for the association of the monomeric annexin A2 to the GM1 phase of PMSs 
could be an elevated Ca2+ concentration in the spheres. As mentioned above a rise in the Ca2+ level 
results in a recruitment of annexin A2 PM to DRMs. This might also hold true for the association of 
annexin A2 to GM1 phases in PMSs. 
Keller and colleagues demonstrated that Ca2+ is an important component of the blebbing solution of 
GPMVs. The induction of the membrane outgrowths is accompanied by a raise of the Ca2+ level inside 
the cells. Only very few vesicles form in the absence of Ca2+ (Keller et al., 2009). It is hypothesised 
that the increase of intracellular Ca2+ leads to restructuration of the plasma membrane. The Ca2+ 
concentration in PMSs or the formation of PMSs in the absence of Ca2+ was not determined. However, 
Keller and co-workers propose that similar mechanisms apply for GPMVs and PMSs formation and 
that Ca2+ is of critical importance (Keller et al., 2009). 
Therefore, the localisation of the monomeric annexin A2 PM variant in the GM1 phase could indeed 
result from high intracellular Ca2+ levels. This interaction could be similar to the DRM association of 
annexin A2 PM at unphysiologically high Ca2+ concentrations. Hence, PMSs are probably not suitable 
model systems to analyse Ca2+ dependent proteins like annexins. In this context, the analysis of a 
double annexin A2 mutant harbouring not only an inactive p11-binding site but also inactive Ca2+-
binding sites (i.e. the annexin A2 PMCM derivative) could be interesting. 
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5.3.3 Laurdan 2-photon analysis of cells expressing annexin A2 variants 
Membrane rafts show a higher order packing than the surrounding membrane and therefore a reduced 
penetration by water molecules. Hence, the membrane condensation can be visualised using a 
polarity-sensitive probe like Laurdan. In order to understand how the condensed membrane phases 
relate to the classical definition of membrane rafts, usually two distinct regions of cellular membranes 
are distinguished. Gaus and colleagues discriminated between regions with a mean GP of 0.10 - 0.25 
corresponding to liquid-disordered domains and domains with a mean GP of 0.35 - 0.55 corresponding 
to liquid ordered domains (Gaus et al., 2006). In combination with the use of fluorescently labelled 
proteins the overlay of the confocal image with the GP image can identify the localisation of proteins in 
liquid-disordered / liquid-ordered (low / high GP value) regions, respectively. 
 
Laurdan studies labelling large unilamellar vesicles containing 3 mol % PI(4,5)P  revealed that 
annexin A2 is capable of inducing a spectral shift of Laurdan, indicating that annexin A2 is able to 
induce the formation of higher ordered membrane domains in model membranes. Annexin A2 variants 
harbouring mutations in the PI(4,5)P -binding site however do not evoke a spectral shift in these 
artificial model systems (Gokhale et al., 2005). 
2
2
 
Here, it was analysed whether the expression of annexin A2 in living cells results in the formation of 
detectable domains of higher order or if the protein specifically localises to ordered membrane 
domains. Furthermore, various annexin A2 derivatives were analysed to investigate if different 
mutations affect this localisation. 
mCherry tagged annexin A2 wt and different annexin A2 mutants were expressed in MDCK and the 
cells were labelled with Laurdan to investigate the membrane order at sites of protein localisation. 
Confocal images of the different proteins revealed a rather typical localisation. Annexin A2 wt as well 
as the phosphorylation mutants YE and YF, the PI(4,5)P2-binding deficient KA mutant and the protein 
with mutated high affinity Ca2+-binding sites are diffusely distributed throughout the cytoplasm and 
excluded from the nucleus. It has been described that p11 binding to annexin A2 prevents a 
sequestration of the complex into the nucleus (Eberhard et al., 2001). Therefore, the p11-binding 
deficient mutants PM and PMCM are not restricted to the cytoplasm but can also be found in the 
nucleus. The staining pattern of these two derivatives is similar to that observed for mCherry that was 
used as a control. 
 
In the GP image of one representative example no regions of increased membrane condensation 
could be detected in the cell except for a few “red patches” in the pseudo-coloured image. Those 
probably arise from precipitated Laurdan. Domains of increased condensation were absent in all cells 
examined. However, it has to be pointed out that the analysed cells show a rather low average GP 
value of about 0.1. A GP value of 0.1 would correspond to liquid-disordered domains. The GP values 
of Laurdan in cells are usually higher. This points the possibility that the experimental setup was not 
optimal. The Laurdan measurements were performed during a three month international laboratory 
exchange in Sydney, Australia, and unfortunately there was not enough time to optimise the 
experimental conditions. 
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The absence of membrane domains that possess an increased membrane order could also be due to 
the fact that the cells were quiescent. To overcome this problem cells could be stimulated to form 
larger domains of higher membrane order that can be resolved with a conventional microscope. Raft 
size can be modulated by oligomerisation of raft components. E.g. the pentameric B-subunit of cholera 
toxin is often used to cluster raft domains. Also antibody-crosslinking of GPI-anchored proteins like 
placental alkaline phosphatise (PLAP) can form optically resolvable membrane microdomains (Harder 
et al., 1998). More high GP domains are revealed in fibroblasts when membrane proteins are cross-
linked (Gaus et al., 2003). And the incubation of T lymphocytes with anti-CD3-coated beads leads to 
domains of higher order at sites of T cell receptor activation (Gaus et al., 2005). 
 
The amount of annexin A2 localised to the membrane in the cells analysed here is rather small. Most 
of the protein is cytosolic. It is reported that annexin A2 preferentially localises to the plasma 
membrane at sites of cell-cell contact (Nigg et al., 1983). Singular cells were investigated here to be 
able to take a look at distinct cell membranes of discrete cells. Therefore, the localisation of 
annexin A2 at cell-cell contacts cannot be seen in this assay. Furthermore, the model cells used here 
were relatively flat. This makes it difficult to image the plasma membrane. At the same time, Laurdan 
internalises very fast and the amount of intracellular staining is fairly high in contrast to the membrane 
staining. Life cell imaging could improve the results (personal communication with Carles Rentero, 
Barcelona, Spain). 
 
No measurable differences were detectable for the degree of membrane order in regions of the 
localisation of different annexin A2 derivatives or an mCherry control. This can probably be explained 
by the fact that regions of increased membrane condensation are missing. From the observation that 
annexin A2 expressing cells are devoid of membrane domains with increased order it could be 
concluded that the expression of this raft associated protein alone is not sufficient to induce the 
formation of Laurdan detectable microdomains in living cells under the experimental conditions chosen 
here. However, this conclusion should be considered with caution since the experimental setup might 
not have been optimal as mentioned above. 
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7 Appendix 
7.1 Abbreviations 
 anti or alpha 
A ampere 
aa amino acid 
AIF apoptosis inducing factor 
anx annexin 
Apaf-1 apoptotic peptidase activating factor 1 
APS ammonium persulfate 
ATP adenosine-5'-triphosphate 
BA bovine albumin 
Bax Bcl-2–associated X protein 
Bcl-2 B-cell lymphoma 2 
Bcl-XL B-cell lymphoma-extra large 
BHK baby hamster kidney 
Bid Bcl-2 interacting domain 
BSA bovine serum albumin 
° C temperature in degree Celsius 
C- carboxyl 
c concentration or cleaved 
Ca calcium 
CHX cycloheximide 
CM calcium minus 
CMEC cardiac microvascular endothelial cells 
C(T) cycle threshold 
CtxB cholera toxin B subunit 
Cy carbocyanine 
Da Dalton 
DEAE dextran diethylaminoethyl dextran 
dist. H2O distilled water 
DICS death-inducing signal complex 
DMEM Dulbecco's Modified Eagle Medium 
DMSO dimethylsulfoxid 
DNA deoxyribonucleic acid 
dNTP deoxynucleotide triphosphate 
DRM detergent resistant membrane 
E. coli Escherichia coli 
EDTA ethylenediaminetetraacetic acid 
e.g. exempli gratia, for example 
EGF enhanced growth factor 
EGFP enhanced green fluorescent protein 
ER endoplasmatic reticulum 
et al.  et altera, and co-workers 
EYFP enhanced yellow fluorescent protein 
FA formaldehyde 
FACS  fluorescence assisted cell sorting  
FADD Fas-associated death domain 
FCS fetal calf serum 
FITC fluorescein isothiocyanate 
FPV avian influenza virus A/Bratislava/79 
fwd forward 
G goat 
g gram or acceleration of gravity 
GAPDH glyceraldehyde 3-phosphate dehydrogenase 
GFP green fluorescent protein from Aequorea victoria 
GM1 monosialotetrahexosylganglioside 
GP Generalised Polarisation 
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GPI glycosylphosphatidylinositol  
GPMV giant plasma membrane vesicle 
h hour(s) 
HA hemagglutinin 
HBV hepatitis B virus 
HCMV human cytomegalovirus 
HEPES 2-(4-(2-Hydroxyethyl)-1-piperazinyl)ethansulfonsäure 
HIV human immunodeficiency virus 
HRP horse reddish peroxidase 
I intensity 
IAP inhibitors of apoptosis 
IAV influenza A virus 
ICT internal charge transfer 
i.e.  id est, that is 
IF immunofluorescence 
IR insulin receptor 
l litre 
Laurdan 6-Dodecanoyl-2-dimethylaminonaphthalene 
LB Luria Bertani 
ld liquid disordered 
LE locally excited 
lo liquid ordered 
LSM laser scanning microscopy 
M molar 
m milli or meter or messenger 
µ micro 
M1 / M 2 matrix protein 1 / matrix protein 2 
MDCK  Madin Darby canine kidney 
MEM minimum essential medium  
MES 2-(N-morpholine)-ethane sulphonic acid 
min minute(s) 
MOI multiplicity of infection 
Ms mouse 
mut mutant 
MW molecular weight 
n nano 
N- amino- 
NA neuraminidase 
n.d. not determined 
NEP nuclear export protein 
NFB nuclear factor kappa-light-chain-enhancer of activated B cells 
NLS nuclear localisation signal 
NP nucleoprotein 
NS-1 non-structural protein 1 
ODxxxnm optical density at xxx nm 
p pico or phospho or plasmid 
P pellet 
PA acidic polymerase protein 
PAG polyacrylamide gel 
PAGE polyacrylamide gel electrophoresis 
PARP poly (ADP-ribose) polymerase 
PB1 / 2 basic polymerase protein 1 / 2 
PBS phosphate buffered saline 
PCR polymerase chain reaction 
PDGF platelet derived growth factor 
PFA paraformaldehyde 
PFU plaque forming units 
PHD pleckstrin-homology domain 
p.i. post infection 
PIC protease inhibitor cocktail 
PI(4,5)P2 phosphatidylinositol-4,5-bisphosphat 
PKC protein kinase C 
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PLAP placental alkaline phosphatise 
PLC phospholipase C 
PM p11 minus 
PMS plasma membrane sphere 
POX peroxidase 
PR8 human influenza A/Puerto-Rico/8/34 
PVDF polyvinylidene fluoride 
R receptor 
Rb rabbit 
rev reverse 
RNA ribonucleic acid 
RNP ribonucleoprotein 
ROS reactive oxygen species 
rpm rounds per minute 
RT room temperature 
s second(s)  
S supernatant or state 
SD standard deviation 
SDS sodium dodecyl sulfate 
si small interfering  
STS staurosporine 
TAE Tris-acetate-EDTA 
TCA trichloro acetic acid 
TE Tris-EDTA-Puffer 
TEMED N,N,N’,N’-tetramethylethylenediamine 
Tet tetracycline 
TN Tris NaCl 
TNF tumour necrosis factor 
Tris Tris(hydroxymethyl)aminomethan 
TxRed Texas Red 
U unit 
v viral 
V Volt 
WB western blot 
wt wildtype 
YFP yellow fluorescent protein 
% (v/v) volume percent per volume 
% (w/v) weight percent per volume 
 
aa are abbreviated by the international one letter or three letter code. 
7.2 Supplementary data 
In the following the influenza A virus titres of the different infection experiments are presented. 
 
Data for Figure 4-3: 
  virus titre (PFU/ml) 
MOI t (h) Tet off Tet on 
virus titre in XM expressing MDCK 
compared to MDCK (%) 
0.01 8 1.4*104 1.1*104 127 
0.1 8 1.1*105 1.1*105 101 
0.0001 24 1.7*103 5.1*103 33 
0.0001 24 3.4*103 1.4*103 255 
0.0001 24 1.1*103 2.1*103 51 
0.001 24 1.1*104 9.2*103 118 
0.001 24 1.7*104 1.5*104 117 
0.001 24 1.9*104 2.7*104 70 
0.1 24 1.3*106 9.3*105 145 
0.1 24 1.1*106 1.4*106 79 
0.1 24 7.1*105 1.3*106 54 
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Data for Figure 4-5: 
  virus titre (PFU/ml) 
virus titre in siRNA transfected HeLa 
compared to untransfected HeLa (%) 
MOI t (h) 
anxA2 
siRNA 
control 
siRNA untransfected anxA2 siRNA control siRNA 
5 6 4.5*105 3.0*105 2.5*105 180 118 
20 6 6.5*106 6.5*106 5.5*106 119 118 
20 6 2.1*106 1.7*106 1.4*106 156 122 
1 8 4.3*105 2.5*105 4.9*105 89 52 
5 8 2.0*106 1.5*106 1.6*106 124 92 
5 8 3.3*105 3.3*105 2.5*105 132 130 
0.01 16 1.9*104 1.6*104 1.2*104 158 129 
0.1 17 3.1*105 6.1*105 6.3*105 48 97 
0.1 16 2.0*105 8.0*104 1.2*105 161 64 
0.1 16 2.1*105 3.5*105 3.8*105 55 92 
0.5 17 7.9*105 2.0*106 2.5*106 32 80 
0.5 16 4.9*105 5.0*105 6.1*105 80 82 
0.5 16 4.0*106 3.3*106 4.9*106 81 67 
 
 
Data for  
Figure 4-7: 
  virus titre (PFU/ml) 
MOI t (h) anxA2 siRNA control siRNA 
virus titre in anxA2 siRNA transfected A549 
compared to control siRNA transfected A549 (%) 
1 8 1.7*103 1.9*103 92 
1 8 5.0*103 7.8*103 65 
1 8 2.3*104 2.2*104 107 
5 8 7.0*104 7.3*104 97 
0.01 24 8.1*102 9.4*102 87 
0.05 24 1.9*104 2.3*104 82 
0.1 24 3.8*101 3.8*101 100 
 
 
Data for Figure 4-8: 
 
A) PR8 
  virus titre (PFU/ml) 
MOI t (h) A2+/+ A2-/- 
virus titre in A2-/- CMEC 
 compared to A2+/+ CMEC (%) 
0.3 8 3.5*105 3.3*105 95.1 
0.1 16 8.5*104 7.6*104 89.4 
0.1 24 6.6*104 4.8*104 72.8 
0.1 24 3.0*104 4.0*104 134.9 
 
B) FPV 
  virus titre (PFU/ml) 
MOI t (h) A2+/+ A2-/- 
virus titre in A2-/- CMEC 
compared to A2+/+ CMEC (%) 
1 8 2.5*106 2.5*106 99 
1 8 1.8*105 1.8*105 99 
0.1 16 5.5*106 6.6*106 121 
0.1 24 2.9*107 3.2*107 111 
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